final_key,job_number,issuer_name,service,cusip6,mt_date,ml_date,record_date,mgmt_rec,proposal,proposal_type,director_number,director_name,Category,Subcategory,Mini_Category,Mini_Subcategory,final_Category,final_Subcategory
"2025-03-11||28252B||To approve the adjournment of the Special Meeting to a later date if necessary to solicit additional proxies if there are not sufficient votes to approve any of the foregoing proposals at the time of the Special Meeting, or any adjournment or postponement thereof.||-1||-1",S06269,1847 HOLDINGS LLC,BD,28252B,3/11/2025,2/4/2025,1/22/2025,F,"To approve the adjournment of the Special Meeting to a later date if necessary to solicit additional proxies if there are not sufficient votes to approve any of the foregoing proposals at the time of the Special Meeting, or any adjournment or postponement thereof.",MG,-1,-1,Shareholder Rights,Omnibus Stock Plan,Shareholder Rights,Meeting Management,Shareholder Rights,Meeting Management
"2025-03-11||28252B||To approve Amendment No. 3 to the 1847 Holdings LLC 2023 Equity Incentive Plan to increase the share reserve to 5,000,000 common shares.||-1||-1",S06269,1847 HOLDINGS LLC,BD,28252B,3/11/2025,2/4/2025,1/22/2025,F,"To approve Amendment No. 3 to the 1847 Holdings LLC 2023 Equity Incentive Plan to increase the share reserve to 5,000,000 common shares.",MG,-1,-1,Shareholder Equity,Capital Accumulation Plan,Compensation,Omnibus Stock Plan,Shareholder Equity,Authorize Stock Increase
"2025-03-11||28252B||Approval has been granted to issue all common shares related to the exercise of Pre-funded warrants, December Series A warrants, and December Series B warrants, all of which were issued on December 16, 2024. This approval encompasses shares issued due to adjustments in warrant terms, including voluntary price adjustments, modifications after a Share Combination Event, changes following the Reset Date, issuance adjustments after a Dilutive Issuance, and alternative cashless exercise provisions.||-1||-1",S06269,1847 HOLDINGS LLC,BD,28252B,3/11/2025,2/4/2025,1/22/2025,F,"Approval has been granted to issue all common shares related to the exercise of Pre-funded warrants, December Series A warrants, and December Series B warrants, all of which were issued on December 16, 2024. This approval encompasses shares issued due to adjustments in warrant terms, including voluntary price adjustments, modifications after a Share Combination Event, changes following the Reset Date, issuance adjustments after a Dilutive Issuance, and alternative cashless exercise provisions.",MG,-1,-1,Shareholder Equity,,Shareholder Equity,Warrants/Bonds/Notes,Shareholder Equity,Warrants/Bonds/Notes
"2025-03-11||28252B||To approve Amendment No. 4 to the Second Amended and Restated Operating Agreement of the Company to increase the number of authorized common shares to 2,000,000,000 shares.||-1||-1",S06269,1847 HOLDINGS LLC,BD,28252B,3/11/2025,2/4/2025,1/22/2025,F,"To approve Amendment No. 4 to the Second Amended and Restated Operating Agreement of the Company to increase the number of authorized common shares to 2,000,000,000 shares.",MG,-1,-1,Corporate Structure,Supermajority Voting,Shareholder Equity,Authorize Stock Increase,Shareholder Equity,Authorize Stock Increase
2025-04-17||002121||Election of Director to serve until the 2026 annual meeting of stockholders and until their successors are duly elected and qualified: Eric Singer||-1||-1,P24770,"A10 NETWORKS, INC.",BN,2121,4/17/2025,3/12/2025,2/21/2025,F,Election of Director to serve until the 2026 annual meeting of stockholders and until their successors are duly elected and qualified: Eric Singer,MG,-1,-1,Board of Directors,Elections,Board of Directors,Elections,Board of Directors,Elections
2024-12-31||655187||Proposal to amend our certificate of incorporation to effect a reverse stock split.||-1||-1,P21745,"ACLARION, INC.",BN,655187,12/31/2024,12/5/2024,11/15/2024,F,Proposal to amend our certificate of incorporation to effect a reverse stock split.,MG,-1,-1,Corporate Structure,Supermajority Voting,Corporate Structure,Miscellaneous Corporate Actions,Shareholder Equity,Stock Splits/Reverse Stock Splits
"2025-04-17||007025||To approve, for the purpose of Nasdaq Marketplace Rule 5635(d), the issuance of shares of common stock underlying common stock purchase warrants originally issued by the Company in July 2024 (the ""July Warrant Proposal"").||-1||-1",Z89366,"ADITXT, INC.",BN,7025,4/17/2025,1/31/2025,1/23/2025,F,"To approve, for the purpose of Nasdaq Marketplace Rule 5635(d), the issuance of shares of common stock underlying common stock purchase warrants originally issued by the Company in July 2024 (the ""July Warrant Proposal"").",MG,-1,-1,Corporate Actions,Spin Off,Shareholder Equity,Warrants/Bonds/Notes,Shareholder Equity,Stock Issuance
"2025-04-17||007025||To approve, for the purpose of Nasdaq Marketplace Rule 5635(d), the issuance of shares of common stock underlying shares of Series A-1 Convertible Preferred Stock originally issued by the Company in December 2023 (the ""Series A-1 Proposal"").||-1||-1",Z89366,"ADITXT, INC.",BN,7025,4/17/2025,1/31/2025,1/23/2025,F,"To approve, for the purpose of Nasdaq Marketplace Rule 5635(d), the issuance of shares of common stock underlying shares of Series A-1 Convertible Preferred Stock originally issued by the Company in December 2023 (the ""Series A-1 Proposal"").",MG,-1,-1,Shareholder Equity,Quorum Requirements,Corporate Structure,Miscellaneous Corporate Actions,Shareholder Equity,Stock Issuance
"2025-04-17||007025||To approve, for the purpose of Nasdaq Marketplace Rule 5635(d), the issuance of shares of common stock underlying shares of Series C-1 Convertible Preferred Stock and common stock purchase warrants originally issued by the Company in May 2024 and August 2024 (the ""Series C-1 Proposal"").||-1||-1",Z89366,"ADITXT, INC.",BN,7025,4/17/2025,1/31/2025,1/23/2025,F,"To approve, for the purpose of Nasdaq Marketplace Rule 5635(d), the issuance of shares of common stock underlying shares of Series C-1 Convertible Preferred Stock and common stock purchase warrants originally issued by the Company in May 2024 and August 2024 (the ""Series C-1 Proposal"").",MG,-1,-1,Corporate Actions,Spin Off,Shareholder Equity,Stock Conversion,Shareholder Equity,Stock Issuance
"2025-04-17||007025||To grant discretionary authority to our BOD to (i) amend our certificate of incorporation to combine outstanding shares of our common stock into a lesser number of outstanding shares, or a ""reverse stock split,"" at a specific ratio within a range of one-for-five (1:5) to a maximum of a one-for-two hundred fifty (1:250) split, with the exact ratio to be determined by our BOD in its sole discretion; and (ii) effect the reverse stock split, if at all, within one year of the date the proposal is approved by stockholders (the ""Reverse Stock Split Proposal"").||-1||-1",Z89366,"ADITXT, INC.",BN,7025,4/17/2025,1/31/2025,1/23/2025,F,"To grant discretionary authority to our BOD to (i) amend our certificate of incorporation to combine outstanding shares of our common stock into a lesser number of outstanding shares, or a ""reverse stock split,"" at a specific ratio within a range of one-for-five (1:5) to a maximum of a one-for-two hundred fifty (1:250) split, with the exact ratio to be determined by our BOD in its sole discretion; and (ii) effect the reverse stock split, if at all, within one year of the date the proposal is approved by stockholders (the ""Reverse Stock Split Proposal"").",MG,-1,-1,,,Corporate Structure,Miscellaneous Corporate Actions,Shareholder Equity,Stock Splits/Reverse Stock Splits
"2025-04-17||007025||To authorize the adjournment of the Special Meeting if necessary or appropriate, including to solicit additional proxies in the event that there are not sufficient votes at the time of the Special Meeting or adjournment or postponement thereof to approve any of the foregoing proposals.||-1||-1",Z89366,"ADITXT, INC.",BN,7025,4/17/2025,1/31/2025,1/23/2025,F,"To authorize the adjournment of the Special Meeting if necessary or appropriate, including to solicit additional proxies in the event that there are not sufficient votes at the time of the Special Meeting or adjournment or postponement thereof to approve any of the foregoing proposals.",MG,-1,-1,Shareholder Rights,Omnibus Stock Plan,Shareholder Rights,Meeting Management,Shareholder Rights,Meeting Management
"2025-02-24||00791X||To authorize, for purposes of complying with NYSE American listing rule 711.05, the issuance of Warrants, shares of Common Stock underlying the Warrants and certain provisions of the Warrants, issued in connection with an offering and sale of securities of the Company that was consummated on January 7, 2025 (the ""Issuance Proposal"").||-1||-1",Z89286,"AEON BIOPHARMA, INC.",SH,00791X,2/24/2025,2/3/2025,1/13/2025,F,"To authorize, for purposes of complying with NYSE American listing rule 711.05, the issuance of Warrants, shares of Common Stock underlying the Warrants and certain provisions of the Warrants, issued in connection with an offering and sale of securities of the Company that was consummated on January 7, 2025 (the ""Issuance Proposal"").",MG,-1,-1,Shareholder Equity,,Shareholder Equity,Warrants/Bonds/Notes,Shareholder Equity,Warrants/Bonds/Notes
"2025-04-30||00901B||To approve a series of alternate amendments to our Certificate of Incorporation to effect, at the option of our Board of Directors, a reverse stock split of our outstanding common stock at a ratio of up to 1-for-100, such ratio to be determined by our Board of Directors in its sole discretion. We refer to this proposal as the ""Reverse Stock Split Proposal"" or ""Proposal 1.""||-1||-1",S12000,AIM IMMUNOTECH INC.,BN,00901B,4/30/2025,4/10/2025,3/25/2025,F,"To approve a series of alternate amendments to our Certificate of Incorporation to effect, at the option of our Board of Directors, a reverse stock split of our outstanding common stock at a ratio of up to 1-for-100, such ratio to be determined by our Board of Directors in its sole discretion. We refer to this proposal as the ""Reverse Stock Split Proposal"" or ""Proposal 1.""",MG,-1,-1,Corporate Actions,Miscellaneous Shareholder Rights,Corporate Structure,Miscellaneous Corporate Actions,Shareholder Equity,Stock Splits/Reverse Stock Splits
2025-05-02||00912X||Advisory vote to approve named executive officer compensation||-1||-1,P27232,AIR LEASE CORPORATION,BN,00912X,5/2/2025,3/26/2025,3/7/2025,F,Advisory vote to approve named executive officer compensation,MG,-1,-1,Compensation,Articles/ByLaws,Compensation,Executive Pay Evaluation (Say on Pay),Compensation,Executive Pay Evaluation (Say on Pay)
"2025-02-28||016230||Election of Director to serve until the 2026 Annual Meeting of Shareholders, and until their respective successors have been duly elected and qualified: Henry R. Slack||-1||-1",P22270,"ALICO, INC.",BN,16230,2/28/2025,1/21/2025,1/3/2025,F,"Election of Director to serve until the 2026 Annual Meeting of Shareholders, and until their respective successors have been duly elected and qualified: Henry R. Slack",MG,-1,-1,Board of Directors,Elections,Board of Directors,Elections,Board of Directors,Elections
2025-03-05||032332||To approve the advisory (non-binding) resolution relating to the named executive officer compensation as disclosed in the accompanying proxy statement.||-1||-1,P20476,"AMTECH SYSTEMS, INC.",BN,32332,3/5/2025,2/6/2025,1/13/2025,F,To approve the advisory (non-binding) resolution relating to the named executive officer compensation as disclosed in the accompanying proxy statement.,MG,-1,-1,Shareholder Rights,Omnibus Stock Plan,Compensation,Executive Pay Evaluation (Say on Pay),Compensation,Executive Pay Evaluation (Say on Pay)
"2025-03-20||03528H||To approve on a non-binding, advisory basis the compensation of our named executive officers.||-1||-1",P22298,"ANIXA BIOSCIENCES, INC.",BN,03528H,3/20/2025,2/11/2025,1/23/2025,F,"To approve on a non-binding, advisory basis the compensation of our named executive officers.",MG,-1,-1,Compensation,Articles/ByLaws,Compensation,Executive Pay Evaluation (Say on Pay),Compensation,Executive Pay Evaluation (Say on Pay)
"2025-02-28||03815U||Approval, in accordance with Nasdaq Listing Rule 5635(d), of the exercisability of certain common stock purchase warrants, and the issuance of the common stock underlying such warrants, which warrants were issued in connection with an offering of securities of the Company that occurred on October 30, 2024.||-1||-1",S01991,"APPLIED DNA SCIENCES, INC.",BN,03815U,2/28/2025,12/13/2024,11/25/2024,F,"Approval, in accordance with Nasdaq Listing Rule 5635(d), of the exercisability of certain common stock purchase warrants, and the issuance of the common stock underlying such warrants, which warrants were issued in connection with an offering of securities of the Company that occurred on October 30, 2024.",MG,-1,-1,Shareholder Equity,Acquisition Agreement,Shareholder Equity,Warrants/Bonds/Notes,Shareholder Equity,Warrants/Bonds/Notes
"2024-12-30||05072K||To authorize, in accordance with Nasdaq Listing Rule 5635(d), the issuance of shares of our common stock pursuant to the Series B Preferred Issuance Proposal.||-1||-1",P20766,AUDDIA INC,BN,05072K,12/30/2024,12/2/2024,11/14/2024,F,"To authorize, in accordance with Nasdaq Listing Rule 5635(d), the issuance of shares of our common stock pursuant to the Series B Preferred Issuance Proposal.",MG,-1,-1,Corporate Actions,Spin Off,Corporate Structure,Miscellaneous Corporate Actions,Shareholder Equity,Stock Issuance
2024-12-30||05072K||Proposal to amend the Company's certificate of incorporation to effect the reverse stock split.||-1||-1,P20766,AUDDIA INC,BN,05072K,12/30/2024,12/2/2024,11/14/2024,F,Proposal to amend the Company's certificate of incorporation to effect the reverse stock split.,MG,-1,-1,Corporate Structure,Supermajority Voting,Corporate Structure,Miscellaneous Corporate Actions,Shareholder Equity,Stock Splits/Reverse Stock Splits
"2025-05-02||05072K||Proposal to grant discretionary authority to our board of directors to amend our Certificate of Incorporation to increase the number of our authorized shares of common stock from 100,000,000 shares to 250,000,000 shares.||-1||-1",S12670,AUDDIA INC,BN,05072K,5/2/2025,4/18/2025,4/4/2025,F,"Proposal to grant discretionary authority to our board of directors to amend our Certificate of Incorporation to increase the number of our authorized shares of common stock from 100,000,000 shares to 250,000,000 shares.",MG,-1,-1,Corporate Structure,Supermajority Voting,Corporate Structure,Miscellaneous Corporate Actions,Shareholder Equity,Authorize Stock Increase
2024-12-30||05072K||To approve an amendment to the Company's 2020 Equity Incentive Plan.||-1||-1,P20766,AUDDIA INC,BN,05072K,12/30/2024,12/2/2024,11/14/2024,F,To approve an amendment to the Company's 2020 Equity Incentive Plan.,MG,-1,-1,Compensation,Health,Compensation,Omnibus Stock Plan,Compensation,Omnibus Stock Plan
"2024-12-30||05072K||The ratification of the appointment of Haynie & Company as the Company's independent registered public accounting firm for the year ending December 31, 2024.||-1||-1",P20766,AUDDIA INC,BN,05072K,12/30/2024,12/2/2024,11/14/2024,F,"The ratification of the appointment of Haynie & Company as the Company's independent registered public accounting firm for the year ending December 31, 2024.",MG,-1,-1,Corporate Governance,Environmental,Corporate Governance,Audit Related,Corporate Governance,Audit Related
"2024-12-30||05072K||Proposal to authorize, in accordance with Nasdaq Listing Rule 5635(d), the issuance of shares of our common stock pursuant to the Company's Equity Line of Credit.||-1||-1",P20766,AUDDIA INC,BN,05072K,12/30/2024,12/2/2024,11/14/2024,F,"Proposal to authorize, in accordance with Nasdaq Listing Rule 5635(d), the issuance of shares of our common stock pursuant to the Company's Equity Line of Credit.",MG,-1,-1,Shareholder Equity,Acquisition Agreement,Shareholder Equity,Stock Issuance,Shareholder Equity,Stock Issuance
"2025-04-24||05350V||Approval of an amendment to the Company's 2021 Long Term Incentive Plan to increase the number of shares reserved for issuance thereunder by 2,250,000 shares.||-1||-1",P25347,"AVANOS MEDICAL,INC.",SH,05350V,4/24/2025,3/14/2025,2/28/2025,F,"Approval of an amendment to the Company's 2021 Long Term Incentive Plan to increase the number of shares reserved for issuance thereunder by 2,250,000 shares.",MG,-1,-1,Compensation,Social,Compensation,Stock Option Plans,Shareholder Equity,Authorize Stock Increase
"2025-02-05||08579W||To approve, on an advisory, non-binding basis, our executive compensation.||-1||-1",P22484,"BERRY GLOBAL GROUP, INC.",BN,08579W,2/5/2025,1/13/2025,1/6/2025,F,"To approve, on an advisory, non-binding basis, our executive compensation.",MG,-1,-1,Compensation,Articles/ByLaws,Compensation,Executive Pay Evaluation (Say on Pay),Compensation,Executive Pay Evaluation (Say on Pay)
"2025-02-25||08579W||Proposal to approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to Berry's named executive officers that is based on or otherwise relates to the transactions contemplated by the Merger Agreement, which proposal is referred to as the ""Berry Advisory Compensation Proposal.""||-1||-1",S05558,"BERRY GLOBAL GROUP, INC.",BN,08579W,2/25/2025,1/29/2025,1/17/2025,F,"Proposal to approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to Berry's named executive officers that is based on or otherwise relates to the transactions contemplated by the Merger Agreement, which proposal is referred to as the ""Berry Advisory Compensation Proposal.""",MG,-1,-1,Compensation,Articles/ByLaws,Compensation,Executive Pay Evaluation (Say on Pay),Compensation,Executive Pay Evaluation (Say on Pay)
"2025-01-15||09075F||To approve a series of alternate amendments to the Company's Amended and Restated Certificate of Incorporation, as amended, to effect, at the option of our Board of Directors, a reverse split of our common stock at a ratio between 1-for-25 and 1-for-75, inclusive, as determined by our Board of Directors in its sole discretion and with such reverse stock split to be effected at such time and date, if at all, as determined by our board of directors in its sole discretion.||-1||-1",S02517,"BIONANO GENOMICS, INC.",BN,09075F,1/15/2025,12/12/2024,11/21/2024,F,"To approve a series of alternate amendments to the Company's Amended and Restated Certificate of Incorporation, as amended, to effect, at the option of our Board of Directors, a reverse split of our common stock at a ratio between 1-for-25 and 1-for-75, inclusive, as determined by our Board of Directors in its sole discretion and with such reverse stock split to be effected at such time and date, if at all, as determined by our board of directors in its sole discretion.",MG,-1,-1,Corporate Structure,Supermajority Voting,Corporate Structure,Miscellaneous Corporate Actions,Shareholder Equity,Stock Splits/Reverse Stock Splits
"2025-01-15||09075F||To approve, for purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of up to an aggregate of 19,762,226 shares of common stock upon the exercise of certain Series C warrants and Series D warrants.||-1||-1",S02517,"BIONANO GENOMICS, INC.",BN,09075F,1/15/2025,12/12/2024,11/21/2024,F,"To approve, for purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of up to an aggregate of 19,762,226 shares of common stock upon the exercise of certain Series C warrants and Series D warrants.",MG,-1,-1,Shareholder Equity,,Shareholder Equity,Warrants/Bonds/Notes,Shareholder Equity,Stock Issuance
"2025-01-13||74933X||To approve, in accordance with NYSE American Company Guide Section 713(a), the issuance of up to 10,695,962 shares of our outstanding common stock, par value $0.0001 per share (""Common Stock""), upon the exercise of our Series K Common Stock Purchase Warrants, with the right for such potential exercise to occur immediately following the date upon which our stockholders approve this proposal (the ""Warrant Exercise Proposal"" or ""Proposal No. 1"").||-1||-1",S02375,"CATHETER PRECISION, INC.",BN,74933X,1/13/2025,12/3/2024,11/18/2024,F,"To approve, in accordance with NYSE American Company Guide Section 713(a), the issuance of up to 10,695,962 shares of our outstanding common stock, par value $0.0001 per share (""Common Stock""), upon the exercise of our Series K Common Stock Purchase Warrants, with the right for such potential exercise to occur immediately following the date upon which our stockholders approve this proposal (the ""Warrant Exercise Proposal"" or ""Proposal No. 1"").",MG,-1,-1,,,Shareholder Equity,Warrants/Bonds/Notes,Shareholder Equity,Warrants/Bonds/Notes
"2025-01-13||74933X||To approve an amendment to our Certificate of Incorporation to increase the number of authorized shares of our Common Stock from thirty (30) million shares to sixty (60) million shares (the ""Certificate Amendment Proposal"" or ""Proposal No. 2"").||-1||-1",S02375,"CATHETER PRECISION, INC.",BN,74933X,1/13/2025,12/3/2024,11/18/2024,F,"To approve an amendment to our Certificate of Incorporation to increase the number of authorized shares of our Common Stock from thirty (30) million shares to sixty (60) million shares (the ""Certificate Amendment Proposal"" or ""Proposal No. 2"").",MG,-1,-1,Corporate Structure,Supermajority Voting,Corporate Structure,Miscellaneous Corporate Actions,Shareholder Equity,Authorize Stock Increase
"2025-03-10||17322U||To approve an amendment to our Articles of Incorporation to increase the authorized number of shares from 26,000,000 to 260,000,000 and the authorized number of common shares from 16,000,000 to 250,000,000.||-1||-1",P22655,"CITIUS PHARMACEUTICALS, INC.",BN,17322U,3/10/2025,1/29/2025,1/14/2025,F,"To approve an amendment to our Articles of Incorporation to increase the authorized number of shares from 26,000,000 to 260,000,000 and the authorized number of common shares from 16,000,000 to 250,000,000.",MG,-1,-1,Corporate Structure,Supermajority Voting,Shareholder Equity,Authorize Stock Increase,Shareholder Equity,Authorize Stock Increase
2025-03-10||17322U||To approve on a non-binding advisory basis our executive compensation.||-1||-1,P22655,"CITIUS PHARMACEUTICALS, INC.",BN,17322U,3/10/2025,1/29/2025,1/14/2025,F,To approve on a non-binding advisory basis our executive compensation.,MG,-1,-1,Compensation,Articles/ByLaws,Compensation,Executive Pay Evaluation (Say on Pay),Compensation,Executive Pay Evaluation (Say on Pay)
2025-04-24||174610||Advisory Vote on Executive Compensation.||-1||-1,P26766,"CITIZENS FINANCIAL GROUP, INC.",BN,174610,4/24/2025,3/17/2025,2/28/2025,F,Advisory Vote on Executive Compensation.,MG,-1,-1,Compensation,Articles/ByLaws,Compensation,Executive Pay Evaluation (Say on Pay),Compensation,Executive Pay Evaluation (Say on Pay)
"2025-01-14||228339||To approve a reverse stock split of our common stock at a ratio of not more than 1-for-200, such ratio to be determined by the Board of Directors on or prior to December 31, 2025, in its sole discretion.||-1||-1",S04340,CROWN ELECTROKINETICS CORP.,BN,228339,1/14/2025,12/27/2024,12/16/2024,F,"To approve a reverse stock split of our common stock at a ratio of not more than 1-for-200, such ratio to be determined by the Board of Directors on or prior to December 31, 2025, in its sole discretion.",MG,-1,-1,Corporate Structure,Supermajority Voting,Corporate Structure,Miscellaneous Corporate Actions,Shareholder Equity,Stock Splits/Reverse Stock Splits
2025-02-04||126389||Approve and adopt the CSP INC. 2025 Stock Incentive Plan.||-1||-1,P22419,CSP INC.,BN,126389,2/4/2025,1/10/2025,12/20/2024,F,Approve and adopt the CSP INC. 2025 Stock Incentive Plan.,MG,-1,-1,Compensation,Social,Compensation,Omnibus Stock Plan,Compensation,Omnibus Stock Plan
"2025-02-06||23254L||The approval of an amendment to the Certificate to increase the number of authorized shares of Common Stock from 100,000,000 shares to 250,000,000 shares, which number would not be adjusted as a result of the Reverse Stock Split Amendment, if such amendment is approved.||-1||-1",Z89260,"CYCLACEL PHARMACEUTICALS, INC.",BN,23254L,2/6/2025,1/22/2025,1/9/2025,F,"The approval of an amendment to the Certificate to increase the number of authorized shares of Common Stock from 100,000,000 shares to 250,000,000 shares, which number would not be adjusted as a result of the Reverse Stock Split Amendment, if such amendment is approved.",MG,-1,-1,Corporate Structure,Supermajority Voting,Shareholder Equity,Authorize Stock Increase,Shareholder Equity,Authorize Stock Increase
"2025-01-30||23257B||Approval of, if necessary, the adjournment or postponement of the Special Meeting, to continue to solicit votes for Proposals 1, 2 and 3.||-1||-1",S02870,CYNGN INC.,BN,23257B,1/30/2025,1/9/2025,12/2/2024,F,"Approval of, if necessary, the adjournment or postponement of the Special Meeting, to continue to solicit votes for Proposals 1, 2 and 3.",MG,-1,-1,Shareholder Rights,Omnibus Stock Plan,Shareholder Rights,Meeting Management,Shareholder Rights,Meeting Management
"2025-01-30||23257B||Grant discretionary authority to our board of directors to (i) amend our certificate of incorporation to combine outstanding shares of our common stock into a lesser number of outstanding shares, or a ""reverse stock split,"" at a specific ratio within a range of one-for-five (1-for-5) to a maximum of a one-for-one hundred fifty (1-for-150) split, with the exact ratio to be determined by our board of directors in its sole discretion; and (ii) effect the reverse stock split, if at all, within one year of the date the proposal is approved by stockholders.||-1||-1",S02870,CYNGN INC.,BN,23257B,1/30/2025,1/9/2025,12/2/2024,F,"Grant discretionary authority to our board of directors to (i) amend our certificate of incorporation to combine outstanding shares of our common stock into a lesser number of outstanding shares, or a ""reverse stock split,"" at a specific ratio within a range of one-for-five (1-for-5) to a maximum of a one-for-one hundred fifty (1-for-150) split, with the exact ratio to be determined by our board of directors in its sole discretion; and (ii) effect the reverse stock split, if at all, within one year of the date the proposal is approved by stockholders.",MG,-1,-1,,,Corporate Structure,Miscellaneous Corporate Actions,Shareholder Equity,Stock Splits/Reverse Stock Splits
"2025-01-30||23257B||Approval of an amendment to the Company's Certificate of Incorporation to increase the number of authorized common stock from 200,000,000 to 400,000,000 shares.||-1||-1",S02870,CYNGN INC.,BN,23257B,1/30/2025,1/9/2025,12/2/2024,F,"Approval of an amendment to the Company's Certificate of Incorporation to increase the number of authorized common stock from 200,000,000 to 400,000,000 shares.",MG,-1,-1,Corporate Structure,Supermajority Voting,Corporate Structure,Miscellaneous Corporate Actions,Shareholder Equity,Authorize Stock Increase
2025-02-03||253798||Company proposal to approve the amendment and restatement of the Digi International Inc. 2021 Omnibus Incentive Plan.||-1||-1,P21220,DIGI INTERNATIONAL INC.,BN,253798,2/3/2025,12/20/2024,12/9/2024,F,Company proposal to approve the amendment and restatement of the Digi International Inc. 2021 Omnibus Incentive Plan.,MG,-1,-1,Compensation,Health,Compensation,Omnibus Stock Plan,Compensation,Omnibus Stock Plan
2025-05-01||26441C||Advisory vote to approve Duke Energy's named executive officer compensation||-1||-1,P24563,DUKE ENERGY CORPORATION,BN,26441C,5/1/2025,3/17/2025,3/3/2025,F,Advisory vote to approve Duke Energy's named executive officer compensation,MG,-1,-1,Compensation,Articles/ByLaws,Compensation,Executive Pay Evaluation (Say on Pay),Compensation,Executive Pay Evaluation (Say on Pay)
"2025-01-17||29405E||To approve an amendment to the Company's Amended and Restated Certificate of Incorporation, as amended (the ""Charter""), to, at the discretion of the Board of Directors of the Company, effect a reverse stock split with respect to the Company's issued and outstanding common stock, par value $0.01 per share, including stock held by the Company as treasury shares, at a ratio of 1-for-10 to 1-for-100 (""Range""), with the ratio within such Range to be determined at the discretion of the Board (the ""Reverse Stock Split Proposal"").||-1||-1",S03115,"ENVERIC BIOSCIENCES, INC.",BN,29405E,1/17/2025,12/20/2024,12/11/2024,F,"To approve an amendment to the Company's Amended and Restated Certificate of Incorporation, as amended (the ""Charter""), to, at the discretion of the Board of Directors of the Company, effect a reverse stock split with respect to the Company's issued and outstanding common stock, par value $0.01 per share, including stock held by the Company as treasury shares, at a ratio of 1-for-10 to 1-for-100 (""Range""), with the ratio within such Range to be determined at the discretion of the Board (the ""Reverse Stock Split Proposal"").",MG,-1,-1,,,Corporate Structure,Miscellaneous Corporate Actions,Shareholder Equity,Stock Splits/Reverse Stock Splits
2025-04-22||29460X||Advisory vote to approve the compensation paid to the named executive officers of the Company.||-1||-1,P27045,"EQUITY BANCSHARES, INC.",BN,29460X,4/22/2025,3/18/2025,2/28/2025,F,Advisory vote to approve the compensation paid to the named executive officers of the Company.,MG,-1,-1,Compensation,Articles/ByLaws,Compensation,Executive Pay Evaluation (Say on Pay),Compensation,Executive Pay Evaluation (Say on Pay)
"2025-04-15||29667D||Approval of an advisory (non-binding) basis, specified compensation that may become payable to the named executive officers of ESSA in connection with the merger.||-1||-1",S10131,"ESSA BANCORP, INC.",BN,29667D,4/15/2025,3/13/2025,2/18/2025,F,"Approval of an advisory (non-binding) basis, specified compensation that may become payable to the named executive officers of ESSA in connection with the merger.",MG,-1,-1,Compensation,Articles/ByLaws,Compensation,Golden Parachutes,Compensation,Executive Pay Evaluation (Say on Pay)
2025-05-01||30040W||Consider an advisory proposal approving the compensation of our Named Executive Officers.||-1||-1,P26823,EVERSOURCE ENERGY,BN,30040W,5/1/2025,3/21/2025,3/4/2025,F,Consider an advisory proposal approving the compensation of our Named Executive Officers.,MG,-1,-1,Compensation,Articles/ByLaws,Compensation,Executive Pay Evaluation (Say on Pay),Compensation,Executive Pay Evaluation (Say on Pay)
"2025-04-29||302491||Approval, by non-binding vote, of executive compensation.||-1||-1",P21001,FMC CORPORATION,BN,302491,4/29/2025,3/21/2025,2/28/2025,F,"Approval, by non-binding vote, of executive compensation.",MG,-1,-1,Compensation,Articles/ByLaws,Compensation,Executive Pay Evaluation (Say on Pay),Compensation,Executive Pay Evaluation (Say on Pay)
2025-01-24||34962G||The approval of an amended and restated 2021 Equity Incentive Plan.||-1||-1,S03007,"FORTE BIOSCIENCES, INC.",BN,34962G,1/24/2025,1/9/2025,12/30/2024,F,The approval of an amended and restated 2021 Equity Incentive Plan.,MG,-1,-1,Compensation,Health,Compensation,Omnibus Stock Plan,Compensation,Omnibus Stock Plan
"2025-04-17||35952H||To approve, on a non-binding advisory basis, the compensation of FuelCell Energy, Inc.'s named executive officers as set forth in the ""Executive Compensation"" section of the Proxy Statement.||-1||-1",P24866,"FUELCELL ENERGY, INC.",BD,35952H,4/17/2025,3/3/2025,2/12/2025,F,"To approve, on a non-binding advisory basis, the compensation of FuelCell Energy, Inc.'s named executive officers as set forth in the ""Executive Compensation"" section of the Proxy Statement.",MG,-1,-1,Compensation,Articles/ByLaws,Compensation,Executive Pay Evaluation (Say on Pay),Compensation,Executive Pay Evaluation (Say on Pay)
2025-04-17||35952H||Election of Director to serve until the 2026 Annual Meeting: James H. England||-1||-1,P24866,"FUELCELL ENERGY, INC.",BD,35952H,4/17/2025,3/3/2025,2/12/2025,F,Election of Director to serve until the 2026 Annual Meeting: James H. England,MG,-1,-1,Shareholder Rights,Board Classification,Board of Directors,Elections,Board of Directors,Elections
"2025-04-17||35952H||To approve the amendment and restatement of the FuelCell Energy, Inc. Fourth Amended and Restated 2018 Omnibus Incentive Plan.||-1||-1",P24866,"FUELCELL ENERGY, INC.",BD,35952H,4/17/2025,3/3/2025,2/12/2025,F,"To approve the amendment and restatement of the FuelCell Energy, Inc. Fourth Amended and Restated 2018 Omnibus Incentive Plan.",MG,-1,-1,Compensation,Health,Compensation,Omnibus Stock Plan,Compensation,Omnibus Stock Plan
2025-04-17||35952H||Election of Director to serve until the 2026 Annual Meeting: Donna Sims Wilson||-1||-1,P24866,"FUELCELL ENERGY, INC.",BD,35952H,4/17/2025,3/3/2025,2/12/2025,F,Election of Director to serve until the 2026 Annual Meeting: Donna Sims Wilson,MG,-1,-1,Board of Directors,Elections,Board of Directors,Elections,Board of Directors,Elections
2025-03-17||36872P||To approve the Genasys Inc. 2025 Equity Incentive Plan.||-1||-1,P22767,GENASYS INC.,BD,36872P,3/17/2025,2/5/2025,1/21/2025,F,To approve the Genasys Inc. 2025 Equity Incentive Plan.,MG,-1,-1,Compensation,Health,Compensation,Omnibus Stock Plan,Compensation,Omnibus Stock Plan
2025-03-17||36872P||To consider an advisory vote on the compensation of our named executive officers.||-1||-1,P22767,GENASYS INC.,BD,36872P,3/17/2025,2/5/2025,1/21/2025,F,To consider an advisory vote on the compensation of our named executive officers.,MG,-1,-1,Compensation,Articles/ByLaws,Compensation,Executive Pay Evaluation (Say on Pay),Compensation,Executive Pay Evaluation (Say on Pay)
2025-02-10||38358M||Election of Director for the term of three years: Robert W. Barlow||-1||-1,P20760,"GOUVERNEUR BANCORP, INC.",BN,38358M,2/10/2025,1/9/2025,12/13/2024,F,Election of Director for the term of three years: Robert W. Barlow,MG,-1,-1,Board of Directors,Elections,Board of Directors,Elections,Board of Directors,Elections
2025-02-10||38358M||Election of Director for the term of three years: David C. McClure||-1||-1,P20760,"GOUVERNEUR BANCORP, INC.",BN,38358M,2/10/2025,1/9/2025,12/13/2024,F,Election of Director for the term of three years: David C. McClure,MG,-1,-1,Board of Directors,Elections,Board of Directors,Elections,Board of Directors,Elections
"2025-02-10||38358M||The approval of the Gouverneur Bancorp, Inc. 2025 Equity Incentive Plan.||-1||-1",P20760,"GOUVERNEUR BANCORP, INC.",BN,38358M,2/10/2025,1/9/2025,12/13/2024,F,"The approval of the Gouverneur Bancorp, Inc. 2025 Equity Incentive Plan.",MG,-1,-1,Corporate Structure,Reorganization Plan,Compensation,Stock Option Plans,Compensation,Stock Option Plans
2025-02-10||38358M||Election of Director for the term of three years: Amy M. Rapholz||-1||-1,P20812,"GOUVERNEUR BANCORP, INC.",SH,38358M,2/10/2025,1/8/2025,12/13/2024,F,Election of Director for the term of three years: Amy M. Rapholz,MG,-1,-1,Board of Directors,Elections,Board of Directors,Elections,Board of Directors,Elections
"2025-04-17||395330||To grant discretionary authority to our board of directors to (i) amend our articles of incorporation to combine outstanding shares of our Common Stock into a lesser number of outstanding shares, or a ""reverse stock split,"" at a specific ratio within a range of (1-for-3)] to a maximum of a (1-for-22)], with the exact ratio to be determined by our board of directors in its sole discretion; and (ii) effect the reverse stock split, if at all, within one year of the date the proposal is approved by stockholders (the ""Reverse Stock Split Proposal"").||-1||-1",S10154,"GREENLANE HOLDINGS, INC.",BN,395330,4/17/2025,3/14/2025,2/21/2025,F,"To grant discretionary authority to our board of directors to (i) amend our articles of incorporation to combine outstanding shares of our Common Stock into a lesser number of outstanding shares, or a ""reverse stock split,"" at a specific ratio within a range of (1-for-3)] to a maximum of a (1-for-22)], with the exact ratio to be determined by our board of directors in its sole discretion; and (ii) effect the reverse stock split, if at all, within one year of the date the proposal is approved by stockholders (the ""Reverse Stock Split Proposal"").",MG,-1,-1,Shareholder Equity,Financial Statements,Corporate Structure,Miscellaneous Corporate Actions,Shareholder Equity,Stock Splits/Reverse Stock Splits
"2025-04-17||395330||To authorize, for purposes of complying with Nasdaq listing rule 5635(d), the issuance of Warrants, shares of Common Stock underlying the Warrants and certain provisions of the Warrants, issued in connection with an offering and sale of securities of the Company that was consummated on February 19, 2025 (the ""Issuance Proposal"").||-1||-1",S10154,"GREENLANE HOLDINGS, INC.",BN,395330,4/17/2025,3/14/2025,2/21/2025,F,"To authorize, for purposes of complying with Nasdaq listing rule 5635(d), the issuance of Warrants, shares of Common Stock underlying the Warrants and certain provisions of the Warrants, issued in connection with an offering and sale of securities of the Company that was consummated on February 19, 2025 (the ""Issuance Proposal"").",MG,-1,-1,Corporate Actions,Spin Off,Shareholder Equity,Warrants/Bonds/Notes,Shareholder Equity,Warrants/Bonds/Notes
"2024-12-31||395330||To approve, in accordance with Nasdaq listing rule 5635(d), the amendment of the 2024 August Warrant to purchase common stock in connection with an offering, and sale of securities of the Company that was consummated on August 13, 2024, to decrease the floor price provision in the event that the Company effects a Reverse Stock Split of its common stock in the future (the ""Reverse Split Floor Price Decrease Proposal"").||-1||-1",P21369,"GREENLANE HOLDINGS, INC.",BN,395330,12/31/2024,12/10/2024,11/25/2024,F,"To approve, in accordance with Nasdaq listing rule 5635(d), the amendment of the 2024 August Warrant to purchase common stock in connection with an offering, and sale of securities of the Company that was consummated on August 13, 2024, to decrease the floor price provision in the event that the Company effects a Reverse Stock Split of its common stock in the future (the ""Reverse Split Floor Price Decrease Proposal"").",MG,-1,-1,Corporate Actions,Spin Off,Corporate Structure,Miscellaneous Corporate Actions,Shareholder Equity,Stock Splits/Reverse Stock Splits
"2025-02-11||3622AW||To approve the adjournment of the Special Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event there are not sufficient votes in favor of the amendment to the Company's Amended and Restated Certificate of Incorporation to effect the Reverse Stock Split.||-1||-1",S05943,GRI BIO INC,BD,3622AW,2/11/2025,1/24/2025,1/6/2025,F,"To approve the adjournment of the Special Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event there are not sufficient votes in favor of the amendment to the Company's Amended and Restated Certificate of Incorporation to effect the Reverse Stock Split.",MG,-1,-1,Shareholder Rights,Omnibus Stock Plan,Corporate Structure,Miscellaneous Corporate Actions,Shareholder Equity,Stock Splits/Reverse Stock Splits
"2025-02-11||3622AW||To approve an amendment to the Company's Amended and Restated Certificate of Incorporation, as amended, to effect a reverse stock split of Company common stock by a ratio of not less than one-for-two and not more than one-for-23 (the ""Reverse Stock Split""), with the exact ratio to be set within this range by our board of directors in its sole discretion (without reducing the authorized number of shares of Company common stock).||-1||-1",S05943,GRI BIO INC,BD,3622AW,2/11/2025,1/24/2025,1/6/2025,F,"To approve an amendment to the Company's Amended and Restated Certificate of Incorporation, as amended, to effect a reverse stock split of Company common stock by a ratio of not less than one-for-two and not more than one-for-23 (the ""Reverse Stock Split""), with the exact ratio to be set within this range by our board of directors in its sole discretion (without reducing the authorized number of shares of Company common stock).",MG,-1,-1,,,Corporate Structure,Miscellaneous Corporate Actions,Shareholder Equity,Stock Splits/Reverse Stock Splits
2025-03-14||422806||Election of Director: Mark H. Hildebrandt||-1||-1,P23202,HEICO CORPORATION,BN,422806,3/14/2025,2/6/2025,1/17/2025,F,Election of Director: Mark H. Hildebrandt,MG,-1,-1,Board of Directors,Elections,Board of Directors,Elections,Board of Directors,Elections
"2025-03-10||426897||Proposal to approve, on an advisory basis, the compensation of the Company's named executive officers.||-1||-1",P25298,"HEPION PHARMACEUTICALS, INC.",BN,426897,3/10/2025,2/19/2025,1/17/2025,F,"Proposal to approve, on an advisory basis, the compensation of the Company's named executive officers.",MG,-1,-1,Compensation,Articles/ByLaws,Compensation,Executive Pay Evaluation (Say on Pay),Compensation,Executive Pay Evaluation (Say on Pay)
"2025-03-10||426897||Proposal to approve an amendment to the Company's Certificate of Incorporation, as amended (the ""Certificate of Incorporation"") to effect a reverse stock split of the Company's common stock at a ratio of between 1-for-10 and 1-for-50, with such ratio to be determined at the sole discretion of the board of directors of the Company and with such Reverse Stock Split to be effected at such time and date, if at all, as determined by the Board in its sole discretion.||-1||-1",P25298,"HEPION PHARMACEUTICALS, INC.",BN,426897,3/10/2025,2/19/2025,1/17/2025,F,"Proposal to approve an amendment to the Company's Certificate of Incorporation, as amended (the ""Certificate of Incorporation"") to effect a reverse stock split of the Company's common stock at a ratio of between 1-for-10 and 1-for-50, with such ratio to be determined at the sole discretion of the board of directors of the Company and with such Reverse Stock Split to be effected at such time and date, if at all, as determined by the Board in its sole discretion.",MG,-1,-1,,,Corporate Structure,Miscellaneous Corporate Actions,Shareholder Equity,Stock Splits/Reverse Stock Splits
"2025-03-10||426897||Election of Director: Kaouthar Lbiati, M.D.||-1||-1",P25298,"HEPION PHARMACEUTICALS, INC.",BN,426897,3/10/2025,2/19/2025,1/17/2025,F,"Election of Director: Kaouthar Lbiati, M.D.",MG,-1,-1,Board of Directors,Elections,Board of Directors,Elections,Board of Directors,Elections
"2024-12-12||426897||Proposal to approve and adopt the Agreement and Plan of Merger (""Merger Agreement""), dated July 19, 2024, by and among Hepion, Pharma Two B Ltd., a company organized under the laws of the State of Israel (""Pharma Two B"") and Pearl Merger Sub Inc., a Delaware corporation and indirect wholly-owned subsidiary of Pharma Two B.||-1||-1",S01652,"HEPION PHARMACEUTICALS, INC.",BN,426897,12/12/2024,11/13/2024,11/6/2024,F,"Proposal to approve and adopt the Agreement and Plan of Merger (""Merger Agreement""), dated July 19, 2024, by and among Hepion, Pharma Two B Ltd., a company organized under the laws of the State of Israel (""Pharma Two B"") and Pearl Merger Sub Inc., a Delaware corporation and indirect wholly-owned subsidiary of Pharma Two B.",MG,-1,-1,,,Corporate Actions,Merger Plan,Corporate Actions,Merger Plan
2025-03-10||426897||Election of Director: John P. Brancaccio||-1||-1,P25298,"HEPION PHARMACEUTICALS, INC.",BN,426897,3/10/2025,2/19/2025,1/17/2025,F,Election of Director: John P. Brancaccio,MG,-1,-1,Board of Directors,Elections,Board of Directors,Elections,Board of Directors,Elections
2025-03-10||426897||Election of Director: Michael Purcell||-1||-1,P25298,"HEPION PHARMACEUTICALS, INC.",BN,426897,3/10/2025,2/19/2025,1/17/2025,F,Election of Director: Michael Purcell,MG,-1,-1,Board of Directors,Elections,Board of Directors,Elections,Board of Directors,Elections
"2025-04-23||G4412G||Approve, on an advisory basis, the compensation of the Company's named executive officers.||-1||-1",P26520,HERBALIFE LTD.,BN,G4412G,4/23/2025,3/18/2025,2/25/2025,F,"Approve, on an advisory basis, the compensation of the Company's named executive officers.",MG,-1,-1,Compensation,Articles/ByLaws,Compensation,Executive Pay Evaluation (Say on Pay),Compensation,Executive Pay Evaluation (Say on Pay)
"2025-03-26||44967K||An amendment to the Company's Certificate of Incorporation, as amended from time to time, to increase the total number of shares of common stock authorized for issuance.||-1||-1",S08691,IMAC HOLDINGS INC,BN,44967K,3/26/2025,2/14/2025,1/27/2025,F,"An amendment to the Company's Certificate of Incorporation, as amended from time to time, to increase the total number of shares of common stock authorized for issuance.",MG,-1,-1,Corporate Structure,Supermajority Voting,Corporate Structure,Miscellaneous Corporate Actions,Shareholder Equity,Authorize Stock Increase
2025-04-17||45769N||Election of Director of the Company for a term of one year: Roger A. Carolin||-1||-1,P26121,"INNOVATIVE SOLUTIONS AND SUPPORT,INC.",BN,45769N,4/17/2025,3/14/2025,2/20/2025,F,Election of Director of the Company for a term of one year: Roger A. Carolin,MG,-1,-1,Board of Directors,Elections,Board of Directors,Elections,Board of Directors,Elections
2025-04-17||45769N||Election of Director of the Company for a term of one year: Shahram Askarpour||-1||-1,P26121,"INNOVATIVE SOLUTIONS AND SUPPORT,INC.",BN,45769N,4/17/2025,3/14/2025,2/20/2025,F,Election of Director of the Company for a term of one year: Shahram Askarpour,MG,-1,-1,Board of Directors,Elections,Board of Directors,Elections,Board of Directors,Elections
2025-04-17||45769N||Election of Director of the Company for a term of one year: Glen R. Bressner||-1||-1,P26121,"INNOVATIVE SOLUTIONS AND SUPPORT,INC.",BN,45769N,4/17/2025,3/14/2025,2/20/2025,F,Election of Director of the Company for a term of one year: Glen R. Bressner,MG,-1,-1,Board of Directors,Elections,Board of Directors,Elections,Board of Directors,Elections
2025-04-17||45769N||Election of Director of the Company for a term of one year: Stephen L. Belland||-1||-1,P26121,"INNOVATIVE SOLUTIONS AND SUPPORT,INC.",BN,45769N,4/17/2025,3/14/2025,2/20/2025,F,Election of Director of the Company for a term of one year: Stephen L. Belland,MG,-1,-1,Board of Directors,Elections,Board of Directors,Elections,Board of Directors,Elections
2025-01-23||466313||Election of Director to serve until the next annual meeting of stockholders or until their respective successors are duly elected and qualified: John C. Plant||-1||-1,P21252,JABIL INC.,BN,466313,1/23/2025,12/17/2024,11/29/2024,F,Election of Director to serve until the next annual meeting of stockholders or until their respective successors are duly elected and qualified: John C. Plant,MG,-1,-1,Board of Directors,Elections,Board of Directors,Elections,Board of Directors,Elections
2025-01-23||466313||Election of Director to serve until the next annual meeting of stockholders or until their respective successors are duly elected and qualified: Steven A. Raymund||-1||-1,P21252,JABIL INC.,BN,466313,1/23/2025,12/17/2024,11/29/2024,F,Election of Director to serve until the next annual meeting of stockholders or until their respective successors are duly elected and qualified: Steven A. Raymund,MG,-1,-1,Board of Directors,Elections,Board of Directors,Elections,Board of Directors,Elections
2025-02-21||47733C||To transact such further or other business as may properly come before the Meeting and any adjournment or postponement thereof.||-1||-1,P23138,JEWETT-CAMERON TRADING COMPANY LTD.,BN,47733C,2/21/2025,1/30/2025,1/17/2025,F,To transact such further or other business as may properly come before the Meeting and any adjournment or postponement thereof.,MG,-1,-1,Shareholder Rights,Omnibus Stock Plan,Shareholder Rights,Meeting Management,Shareholder Rights,Meeting Management
"2025-02-21||47733C||Appointment of Davidson & Company LLP, Chartered Professional Accountants as Auditors of the Company for the ensuing year and authorizing the Directors to fix their remuneration.||-1||-1",P23138,JEWETT-CAMERON TRADING COMPANY LTD.,BN,47733C,2/21/2025,1/30/2025,1/17/2025,F,"Appointment of Davidson & Company LLP, Chartered Professional Accountants as Auditors of the Company for the ensuing year and authorizing the Directors to fix their remuneration.",MG,-1,-1,Corporate Governance,Environmental,Corporate Governance,Audit Related,Corporate Governance,Audit Related
2025-05-01||516544||Election of Class I Director: Mr. Samuel Leno||-1||-1,P25626,"LANTHEUS HOLDINGS, INC.",BN,516544,5/1/2025,3/31/2025,3/3/2025,F,Election of Class I Director: Mr. Samuel Leno,MG,-1,-1,Board of Directors,Elections,Board of Directors,Elections,Board of Directors,Elections
"2025-05-02||518415||To approve on a non-binding, advisory basis, our Named Executive Officers' compensation.||-1||-1",P26926,LATTICE SEMICONDUCTOR CORPORATION,BN,518415,5/2/2025,3/25/2025,3/3/2025,F,"To approve on a non-binding, advisory basis, our Named Executive Officers' compensation.",MG,-1,-1,Compensation,Articles/ByLaws,Compensation,Executive Pay Evaluation (Say on Pay),Compensation,Executive Pay Evaluation (Say on Pay)
2025-02-27||523768||Approve to amend the 2020 Long-Term Incentive Plan.||-1||-1,P21595,"LEE ENTERPRISES, INCORPORATED",SH,523768,2/27/2025,1/28/2025,12/31/2024,F,Approve to amend the 2020 Long-Term Incentive Plan.,MG,-1,-1,Compensation,Health,Compensation,Stock Option Plans,Compensation,Omnibus Stock Plan
2025-04-15||53115L||Approve an amendment to the Company's certificate of incorporation to delete the waiver of Section 203 of the Delaware General Corporation Law.||-1||-1,P25793,LIBERTY ENERGY INC.,BN,53115L,4/15/2025,3/13/2025,2/19/2025,F,Approve an amendment to the Company's certificate of incorporation to delete the waiver of Section 203 of the Delaware General Corporation Law.,MG,-1,-1,Corporate Governance,Investment Advisory Agreement,Corporate Structure,Miscellaneous Corporate Actions,Corporate Structure,Miscellaneous Corporate Actions
"2025-04-09||532746||To vote on an advisory resolution to approve the compensation of the Named Executive Officers as disclosed in this proxy statement (""Proposal 2"").||-1||-1",P25367,LIMONEIRA COMPANY,BN,532746,4/9/2025,3/4/2025,2/12/2025,F,"To vote on an advisory resolution to approve the compensation of the Named Executive Officers as disclosed in this proxy statement (""Proposal 2"").",MG,-1,-1,Compensation,Articles/ByLaws,Compensation,Executive Pay Evaluation (Say on Pay),Compensation,Executive Pay Evaluation (Say on Pay)
"2025-03-27||67091J||To approve, for purposes of Rule 5635(d) of The Nasdaq Stock Market LLC, the issuance of 20% or more of the Company's outstanding shares of common stock, par value $0.0001 per share (""Common Stock""), upon exercise of the Company's Series C common stock purchase warrants and the Company's Series D common stock purchase warrants, dated February 18, 2025.||-1||-1",S10023,"LOGICMARK, INC.",BN,67091J,3/27/2025,3/14/2025,2/18/2025,F,"To approve, for purposes of Rule 5635(d) of The Nasdaq Stock Market LLC, the issuance of 20% or more of the Company's outstanding shares of common stock, par value $0.0001 per share (""Common Stock""), upon exercise of the Company's Series C common stock purchase warrants and the Company's Series D common stock purchase warrants, dated February 18, 2025.",MG,-1,-1,,,Corporate Structure,Investment Advisory Agreement,Shareholder Equity,Stock Issuance
"2025-04-30||56585A||Approval, on an advisory basis, of the company's named executive officer compensation.||-1||-1",P22201,MARATHON PETROLEUM CORPORATION,BN,56585A,4/30/2025,3/26/2025,3/3/2025,F,"Approval, on an advisory basis, of the company's named executive officer compensation.",MG,-1,-1,Compensation,Articles/ByLaws,Compensation,Executive Pay Evaluation (Say on Pay),Compensation,Executive Pay Evaluation (Say on Pay)
2025-04-29||574795||Election of Director: Catherine Szyman||-1||-1,P24742,MASIMO CORPORATION,BN,574795,4/29/2025,4/4/2025,3/3/2025,F,Election of Director: Catherine Szyman,MG,-1,-1,Board of Directors,Elections,Board of Directors,Elections,Board of Directors,Elections
2025-04-29||574795||An advisory vote to approve the compensation of our named executive officers.||-1||-1,P24742,MASIMO CORPORATION,BN,574795,4/29/2025,4/4/2025,3/3/2025,F,An advisory vote to approve the compensation of our named executive officers.,MG,-1,-1,Compensation,Articles/ByLaws,Compensation,Executive Pay Evaluation (Say on Pay),Compensation,Executive Pay Evaluation (Say on Pay)
"2025-01-30||55279B||To approve, on an advisory basis, the compensation of our named executive officers as disclosed in the Proxy Statement.||-1||-1",P22004,"MEI PHARMA, INC.",BN,55279B,1/30/2025,12/30/2024,12/9/2024,F,"To approve, on an advisory basis, the compensation of our named executive officers as disclosed in the Proxy Statement.",MG,-1,-1,Compensation,Articles/ByLaws,Compensation,Executive Pay Evaluation (Say on Pay),Compensation,Executive Pay Evaluation (Say on Pay)
2025-03-04||606710||Election of Director to serve until our 2026 annual meeting of stockholders and until their respective successors have been elected and qualified: Kimberly S. Stevenson||-1||-1,P22743,"MITEK SYSTEMS, INC.",BN,606710,3/4/2025,2/3/2025,1/17/2025,F,Election of Director to serve until our 2026 annual meeting of stockholders and until their respective successors have been elected and qualified: Kimberly S. Stevenson,MG,-1,-1,Board of Directors,Elections,Board of Directors,Elections,Board of Directors,Elections
2025-03-04||606710||Election of Director to serve until our 2026 annual meeting of stockholders and until their respective successors have been elected and qualified: Rahul Gupta||-1||-1,P22743,"MITEK SYSTEMS, INC.",BN,606710,3/4/2025,2/3/2025,1/17/2025,F,Election of Director to serve until our 2026 annual meeting of stockholders and until their respective successors have been elected and qualified: Rahul Gupta,MG,-1,-1,Corporate Governance,Investment Advisory Agreement,Board of Directors,Elections,Board of Directors,Elections
2025-03-04||606710||Election of Director to serve until our 2026 annual meeting of stockholders and until their respective successors have been elected and qualified: James D. Fay||-1||-1,P22743,"MITEK SYSTEMS, INC.",BN,606710,3/4/2025,2/3/2025,1/17/2025,F,Election of Director to serve until our 2026 annual meeting of stockholders and until their respective successors have been elected and qualified: James D. Fay,MG,-1,-1,Board of Directors,Elections,Board of Directors,Elections,Board of Directors,Elections
2025-03-04||606710||Election of Director to serve until our 2026 annual meeting of stockholders and until their respective successors have been elected and qualified: Susan Repo||-1||-1,P22743,"MITEK SYSTEMS, INC.",BN,606710,3/4/2025,2/3/2025,1/17/2025,F,Election of Director to serve until our 2026 annual meeting of stockholders and until their respective successors have been elected and qualified: Susan Repo,MG,-1,-1,Board of Directors,Elections,Board of Directors,Elections,Board of Directors,Elections
"2025-03-04||606710||To approve, on an advisory (non-binding) basis, the compensaiton of our named executive officers as presented in the Proxy Statement accompanying this notice.||-1||-1",P22743,"MITEK SYSTEMS, INC.",BN,606710,3/4/2025,2/3/2025,1/17/2025,F,"To approve, on an advisory (non-binding) basis, the compensaiton of our named executive officers as presented in the Proxy Statement accompanying this notice.",MG,-1,-1,Compensation,Articles/ByLaws,Compensation,Executive Pay Evaluation (Say on Pay),Compensation,Executive Pay Evaluation (Say on Pay)
2025-03-04||606710||Election of Director to serve until our 2026 annual meeting of stockholders and until their respective successors have been elected and qualified: Scott Carter||-1||-1,P22743,"MITEK SYSTEMS, INC.",BN,606710,3/4/2025,2/3/2025,1/17/2025,F,Election of Director to serve until our 2026 annual meeting of stockholders and until their respective successors have been elected and qualified: Scott Carter,MG,-1,-1,Board of Directors,Elections,Board of Directors,Elections,Board of Directors,Elections
"2025-02-28||60785L||To approve an amendment to the Amended and Restated 2017 Equity Incentive Plan to increase by 3,000,000 the number of shares of common stock available for issuance.||-1||-1",P23302,MODULAR MEDICAL INC,BN,60785L,2/28/2025,2/3/2025,1/17/2025,F,"To approve an amendment to the Amended and Restated 2017 Equity Incentive Plan to increase by 3,000,000 the number of shares of common stock available for issuance.",MG,-1,-1,Compensation,Health,Compensation,Omnibus Stock Plan,Compensation,Omnibus Stock Plan
"2025-04-30||60855R||To consider and approve, on a non-binding, advisory basis, the compensation of our named executive officers.||-1||-1",P24787,"MOLINA HEALTHCARE, INC.",BD,60855R,4/30/2025,3/25/2025,3/7/2025,F,"To consider and approve, on a non-binding, advisory basis, the compensation of our named executive officers.",MG,-1,-1,Compensation,Articles/ByLaws,Compensation,Executive Pay Evaluation (Say on Pay),Compensation,Executive Pay Evaluation (Say on Pay)
"2025-04-25||62011B||Approval to adjourn the 2025 Annual Meeting to a later date, if necessary or appropriate, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of Proposal No. 4.||-1||-1",P28868,MOTORSPORT GAMES INC.,BN,62011B,4/25/2025,3/31/2025,3/11/2025,F,"Approval to adjourn the 2025 Annual Meeting to a later date, if necessary or appropriate, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of Proposal No. 4.",MG,-1,-1,Shareholder Rights,Omnibus Stock Plan,Shareholder Rights,Meeting Management,Shareholder Rights,Meeting Management
"2025-04-25||62011B||Approval of the exercise of warrants issued on July 29, 2024 to purchase up to an aggregate of 949,310 shares of Class A Common Stock under applicable rules and regulations of the Nasdaq Stock Market LLC.||-1||-1",P28868,MOTORSPORT GAMES INC.,BN,62011B,4/25/2025,3/31/2025,3/11/2025,F,"Approval of the exercise of warrants issued on July 29, 2024 to purchase up to an aggregate of 949,310 shares of Class A Common Stock under applicable rules and regulations of the Nasdaq Stock Market LLC.",MG,-1,-1,Shareholder Equity,,Shareholder Equity,Warrants/Bonds/Notes,Shareholder Equity,Warrants/Bonds/Notes
"2025-04-25||62011B||Approval of an amendment to the Amended and Restated Motorsport Games Inc. 2021 Equity Incentive Plan to increase the number of shares of the Company's Class A common stock available for awards thereunder by 200,000 shares.||-1||-1",P28868,MOTORSPORT GAMES INC.,BN,62011B,4/25/2025,3/31/2025,3/11/2025,F,"Approval of an amendment to the Amended and Restated Motorsport Games Inc. 2021 Equity Incentive Plan to increase the number of shares of the Company's Class A common stock available for awards thereunder by 200,000 shares.",MG,-1,-1,Compensation,Health,Compensation,Omnibus Stock Plan,Shareholder Equity,Authorize Stock Increase
"2025-02-24||63008J||Approval, for purposes of complying with Nasdaq Listing Rule 5635(d), of the issuance of shares of the Company's common stock underlying certain warrants issued by the Company pursuant that certain Securities Exchange Agreement, dated January 7, 2025, upon exercise of such warrants in an amount equal to or in excess of 20% of the Company's common stock outstanding immediately prior to the execution of the Securities Exchange Agreement.||-1||-1",S08140,"NANOVIBRONIX, INC.",BN,63008J,2/24/2025,1/29/2025,1/17/2025,F,"Approval, for purposes of complying with Nasdaq Listing Rule 5635(d), of the issuance of shares of the Company's common stock underlying certain warrants issued by the Company pursuant that certain Securities Exchange Agreement, dated January 7, 2025, upon exercise of such warrants in an amount equal to or in excess of 20% of the Company's common stock outstanding immediately prior to the execution of the Securities Exchange Agreement.",MG,-1,-1,Shareholder Equity,Acquisition Agreement,Corporate Structure,Miscellaneous Corporate Actions,Shareholder Equity,Warrants/Bonds/Notes
"2025-02-24||63008J||Approval of an amendment to the Company's Amended and Restated Certificate of Incorporation, as amended, to effect, at the discretion of the Company's Board of Directors but prior to the one-year anniversary of the date on which the reverse stock split is approved by the Company's stockholders at the Special Meeting, a reverse stock split of all of the outstanding shares of the Company's common stock, at a ratio in the range of 1-for- 2 to 1-for-11, with such ratio to be determined by the Board of Directors in its discretion & included in a public announcement.||-1||-1",S08140,"NANOVIBRONIX, INC.",BN,63008J,2/24/2025,1/29/2025,1/17/2025,F,"Approval of an amendment to the Company's Amended and Restated Certificate of Incorporation, as amended, to effect, at the discretion of the Company's Board of Directors but prior to the one-year anniversary of the date on which the reverse stock split is approved by the Company's stockholders at the Special Meeting, a reverse stock split of all of the outstanding shares of the Company's common stock, at a ratio in the range of 1-for- 2 to 1-for-11, with such ratio to be determined by the Board of Directors in its discretion & included in a public announcement.",MG,-1,-1,Corporate Actions,Miscellaneous Shareholder Rights,Corporate Structure,Miscellaneous Corporate Actions,Shareholder Equity,Stock Splits/Reverse Stock Splits
"2025-05-01||635309||To approve, on an advisory basis, our executive compensation||-1||-1",P26928,"NATIONAL CINEMEDIA, INC.",BN,635309,5/1/2025,3/24/2025,3/10/2025,F,"To approve, on an advisory basis, our executive compensation",MG,-1,-1,Compensation,Articles/ByLaws,Compensation,Executive Pay Evaluation (Say on Pay),Compensation,Executive Pay Evaluation (Say on Pay)
2025-01-15||63911H||To approve an amendment to our Second Amended and Restated Certificate of Incorporation.||-1||-1,S99556,"NAUTICUS ROBOTICS, INC.",BN,63911H,1/15/2025,11/29/2024,11/4/2024,F,To approve an amendment to our Second Amended and Restated Certificate of Incorporation.,MG,-1,-1,Corporate Structure,Supermajority Voting,Corporate Structure,Miscellaneous Corporate Actions,Corporate Structure,Miscellaneous Corporate Actions
2025-05-02||65441V||Approval of the Third Amendment to the 2011 Stock incentive Plan||-1||-1,P26667,"NINE ENERGY SERVICE, INC.",BN,65441V,5/2/2025,3/21/2025,3/3/2025,F,Approval of the Third Amendment to the 2011 Stock incentive Plan,MG,-1,-1,Compensation,Health,Compensation,Stock Option Plans,Compensation,Omnibus Stock Plan
2025-04-22||669549||Election of Director: Ralph A. Matergia||-1||-1,P27193,NORWOOD FINANCIAL CORP.,BN,669549,4/22/2025,3/21/2025,3/4/2025,F,Election of Director: Ralph A. Matergia,MG,-1,-1,Board of Directors,Elections,Board of Directors,Elections,Board of Directors,Elections
"2025-03-04||67401P||To authorize the Company, with the approval of the Board of Directors, to sell or otherwise issue shares of its common stock at a price below its then current net asset value per share, provided that the number of shares issued does not exceed 25% of its then outstanding common stock.||-1||-1",S03087,OAKTREE SPECIALTY LENDING CORPORATION,BN,67401P,3/4/2025,1/16/2025,1/3/2025,F,"To authorize the Company, with the approval of the Board of Directors, to sell or otherwise issue shares of its common stock at a price below its then current net asset value per share, provided that the number of shares issued does not exceed 25% of its then outstanding common stock.",MG,-1,-1,Shareholder Equity,,Shareholder Equity,Stock Issuance,Shareholder Equity,Stock Issuance
"2025-04-30||674870||To approve an amendment to our Certificate of Incorporation to increase the number of authorized shares of common stock, par value $.001 per share (the ""Common Stock""), from 200,000,000 to 300,000,000.||-1||-1",S11640,"OCEAN POWER TECHNOLOGIES, INC.",BN,674870,4/30/2025,3/31/2025,3/17/2025,F,"To approve an amendment to our Certificate of Incorporation to increase the number of authorized shares of common stock, par value $.001 per share (the ""Common Stock""), from 200,000,000 to 300,000,000.",MG,-1,-1,,,Shareholder Equity,Authorize Stock Increase,Shareholder Equity,Authorize Stock Increase
"2025-05-02||684023||To approve an amendment to the Company's 2021 Equity Incentive Plan to increase the number of common shares available for issuance under the Plan to 3,166,667 shares of Common Stock.||-1||-1",P28298,"ORAGENICS, INC.",BN,684023,5/2/2025,4/7/2025,3/21/2025,F,"To approve an amendment to the Company's 2021 Equity Incentive Plan to increase the number of common shares available for issuance under the Plan to 3,166,667 shares of Common Stock.",MG,-1,-1,Compensation,Employee Stock Purchase Program,Compensation,Omnibus Stock Plan,Shareholder Equity,Authorize Stock Increase
2025-05-02||684023||Advisory vote on executive compensation.||-1||-1,P28298,"ORAGENICS, INC.",BN,684023,5/2/2025,4/7/2025,3/21/2025,F,Advisory vote on executive compensation.,MG,-1,-1,Compensation,Articles/ByLaws,Compensation,Executive Pay Evaluation (Say on Pay),Compensation,Executive Pay Evaluation (Say on Pay)
"2025-05-02||684023||Approval of an amendment to the Company's Articles of Incorporation, as amended, to increase the Company's authorized shares of common stock to 350,000,000 in the event a Reverse Stock Split of our common stock is effectuated prior to approval of the Reverse Stock Split Proposal.||-1||-1",P28298,"ORAGENICS, INC.",BN,684023,5/2/2025,4/7/2025,3/21/2025,F,"Approval of an amendment to the Company's Articles of Incorporation, as amended, to increase the Company's authorized shares of common stock to 350,000,000 in the event a Reverse Stock Split of our common stock is effectuated prior to approval of the Reverse Stock Split Proposal.",MG,-1,-1,Corporate Structure,Supermajority Voting,Corporate Structure,Miscellaneous Corporate Actions,Shareholder Equity,Stock Splits/Reverse Stock Splits
"2025-05-02||684023||Approval of a proposal to authorize the Company's Board of Directors, in its discretion at any time within one year after shareholder approval is obtained, to effect a Reverse Stock Split of then-outstanding shares of the Company's Common Stock, at a ratio of not less than one-for-five (1:5) and not greater than one-for-fifty (1:50), with the exact ratio to be determined by the Company's Board.||-1||-1",P28298,"ORAGENICS, INC.",BN,684023,5/2/2025,4/7/2025,3/21/2025,F,"Approval of a proposal to authorize the Company's Board of Directors, in its discretion at any time within one year after shareholder approval is obtained, to effect a Reverse Stock Split of then-outstanding shares of the Company's Common Stock, at a ratio of not less than one-for-five (1:5) and not greater than one-for-fifty (1:50), with the exact ratio to be determined by the Company's Board.",MG,-1,-1,Corporate Actions,Spin Off,Corporate Structure,Miscellaneous Corporate Actions,Shareholder Equity,Stock Splits/Reverse Stock Splits
2025-04-29||693718||Advisory resolution to approve executive compensation||-1||-1,P26810,PACCAR INC,BN,693718,4/29/2025,3/20/2025,3/4/2025,F,Advisory resolution to approve executive compensation,MG,-1,-1,Compensation,Articles/ByLaws,Compensation,Executive Pay Evaluation (Say on Pay),Compensation,Executive Pay Evaluation (Say on Pay)
2025-04-22||700885||Election of Director of the Company to a term of three years: Fred G. Choate||-1||-1,P27759,"PARKE BANCORP, INC.",BN,700885,4/22/2025,3/25/2025,3/12/2025,F,Election of Director of the Company to a term of three years: Fred G. Choate,MG,-1,-1,Board of Directors,Elections,Board of Directors,Elections,Board of Directors,Elections
2025-02-04||70806A||Election of Director: Adam Bernstein||-1||-1,P21648,PENNANTPARK FLOATING RATE CAPITAL LTD.,BN,70806A,2/4/2025,12/19/2024,12/4/2024,F,Election of Director: Adam Bernstein,MG,-1,-1,Board of Directors,Elections,Board of Directors,Elections,Board of Directors,Elections
"2025-04-22||708430||A proposal to approve, on an advisory basis, specified compensation that may be payable to the named executive officers of Penns Woods in connection with the merger.||-1||-1",S09977,"PENNS WOODS BANCORP, INC.",BN,708430,4/22/2025,2/26/2025,2/19/2025,F,"A proposal to approve, on an advisory basis, specified compensation that may be payable to the named executive officers of Penns Woods in connection with the merger.",MG,-1,-1,Compensation,Articles/ByLaws,Compensation,Golden Parachutes,Compensation,Executive Pay Evaluation (Say on Pay)
"2025-04-10||71678J||To approve an amendment to our Amended and Restated Certificate of Incorporation to effect, at the discretion of the Board but prior to the one-year anniversary of the date on which the reverse stock split is approved by the Company's stockholders at the Special Meeting, a reverse stock split of all of the outstanding shares of our Common Stock, at a ratio in the range of 1-for-250 to 1-for-500, with such ratio to be determined by the Board in its discretion and included in a public announcement.||-1||-1",S10163,"PETROS PHARMACEUTICALS, INC.",BN,71678J,4/10/2025,3/25/2025,2/19/2025,F,"To approve an amendment to our Amended and Restated Certificate of Incorporation to effect, at the discretion of the Board but prior to the one-year anniversary of the date on which the reverse stock split is approved by the Company's stockholders at the Special Meeting, a reverse stock split of all of the outstanding shares of our Common Stock, at a ratio in the range of 1-for-250 to 1-for-500, with such ratio to be determined by the Board in its discretion and included in a public announcement.",MG,-1,-1,Corporate Structure,Supermajority Voting,Corporate Structure,Miscellaneous Corporate Actions,Shareholder Equity,Stock Splits/Reverse Stock Splits
"2025-04-10||71678J||To approve a proposal to adjourn the Special Meeting to a later date or dates, if necessary or appropriate, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of any one or more of the foregoing proposals.||-1||-1",S10163,"PETROS PHARMACEUTICALS, INC.",BN,71678J,4/10/2025,3/25/2025,2/19/2025,F,"To approve a proposal to adjourn the Special Meeting to a later date or dates, if necessary or appropriate, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of any one or more of the foregoing proposals.",MG,-1,-1,Shareholder Rights,Omnibus Stock Plan,Shareholder Rights,Meeting Management,Shareholder Rights,Meeting Management
2025-04-24||717081||2025 advisory approval of executive compensation||-1||-1,P26510,PFIZER INC.,BN,717081,4/24/2025,3/17/2025,2/26/2025,F,2025 advisory approval of executive compensation,MG,-1,-1,Compensation,Articles/ByLaws,Compensation,Executive Pay Evaluation (Say on Pay),Compensation,Executive Pay Evaluation (Say on Pay)
"2025-03-26||73017P||To approve the adjournment of the Special Shareholders Meeting, if necessary, to solicit additional votes if there are insufficient votes at the time of the Special Meeting to approve one or more of the proposals.||-1||-1",Z89434,PMGC HOLDINGS INC.,BN,73017P,3/26/2025,3/10/2025,2/5/2025,F,"To approve the adjournment of the Special Shareholders Meeting, if necessary, to solicit additional votes if there are insufficient votes at the time of the Special Meeting to approve one or more of the proposals.",MG,-1,-1,Shareholder Rights,Omnibus Stock Plan,Shareholder Rights,Meeting Management,Shareholder Rights,Meeting Management
"2025-03-26||73017P||To approve the issuance of 3,036,437 shares of non-trading, non-convertible Series B Preferred Stock to GB Capital Ltd, a British Columbia, Canada corporation, wholly owned by our Chief Executive Officer, Chief Financial Officer, and Director, Graydon Bensler, as a signing bonus pursuant to that certain Second Amended and Restated Consulting Agreement for Non-Employee Chief Executive Officer between the Company and GB Capital, as amended.||-1||-1",Z89434,PMGC HOLDINGS INC.,BN,73017P,3/26/2025,3/10/2025,2/5/2025,F,"To approve the issuance of 3,036,437 shares of non-trading, non-convertible Series B Preferred Stock to GB Capital Ltd, a British Columbia, Canada corporation, wholly owned by our Chief Executive Officer, Chief Financial Officer, and Director, Graydon Bensler, as a signing bonus pursuant to that certain Second Amended and Restated Consulting Agreement for Non-Employee Chief Executive Officer between the Company and GB Capital, as amended.",MG,-1,-1,Compensation,Animal Rights,Compensation,Cash/Stock Bonus Plan,Compensation,Cash/Stock Bonus Plan
"2025-03-26||73017P||To approve the issuance of 138,484 shares of Common Stock, in the aggregate, upon the exercise of warrants issued to certain investors pursuant to that certain Warrant Inducement Agreement entered into between the Company and certain investors on January 27, 2025, and approval of the adjustment terms as set forth in the warrants.||-1||-1",Z89434,PMGC HOLDINGS INC.,BN,73017P,3/26/2025,3/10/2025,2/5/2025,F,"To approve the issuance of 138,484 shares of Common Stock, in the aggregate, upon the exercise of warrants issued to certain investors pursuant to that certain Warrant Inducement Agreement entered into between the Company and certain investors on January 27, 2025, and approval of the adjustment terms as set forth in the warrants.",MG,-1,-1,Shareholder Equity,,Shareholder Equity,Warrants/Bonds/Notes,Shareholder Equity,Warrants/Bonds/Notes
"2025-03-26||73017P||To approve an amendment to our Articles of Incorporation to increase the authorized shares of Common Stock from 285,714,286 million to 10 billion.||-1||-1",Z89434,PMGC HOLDINGS INC.,BN,73017P,3/26/2025,3/10/2025,2/5/2025,F,"To approve an amendment to our Articles of Incorporation to increase the authorized shares of Common Stock from 285,714,286 million to 10 billion.",MG,-1,-1,Corporate Structure,Supermajority Voting,Corporate Structure,Miscellaneous Corporate Actions,Shareholder Equity,Authorize Stock Increase
"2025-03-26||73017P||To approve an amendment to our Bylaws to provide for a staggered Board comprised of two classes of directors, designated Class I and Class II, with Class I Directors serving for three (3) year terms and Class II Directors serving for one (1) year terms.||-1||-1",Z89434,PMGC HOLDINGS INC.,BN,73017P,3/26/2025,3/10/2025,2/5/2025,F,"To approve an amendment to our Bylaws to provide for a staggered Board comprised of two classes of directors, designated Class I and Class II, with Class I Directors serving for three (3) year terms and Class II Directors serving for one (1) year terms.",MG,-1,-1,Board of Directors,Executive Pay Evaluation (Say on Pay),Board of Directors,Board Classification,Board of Directors,Board Classification
2025-01-30||737446||Advisory approval of the Company's executive compensation.||-1||-1,P21230,"POST HOLDINGS, INC.",BN,737446,1/30/2025,12/10/2024,11/25/2024,F,Advisory approval of the Company's executive compensation.,MG,-1,-1,Compensation,Articles/ByLaws,Compensation,Executive Pay Evaluation (Say on Pay),Compensation,Executive Pay Evaluation (Say on Pay)
2024-12-30||74039M||Vote on a non-binding advisory resolution to approve compensation of the Company's executive officers.||-1||-1,P21329,PREDICTIVE ONCOLOGY INC.,BN,74039M,12/30/2024,12/5/2024,11/27/2024,F,Vote on a non-binding advisory resolution to approve compensation of the Company's executive officers.,MG,-1,-1,Compensation,Articles/ByLaws,Compensation,Executive Pay Evaluation (Say on Pay),Compensation,Executive Pay Evaluation (Say on Pay)
2024-12-30||74039M||Vote on a proposal to approve the 2024 Equity Incentive Plan.||-1||-1,P21329,PREDICTIVE ONCOLOGY INC.,BN,74039M,12/30/2024,12/5/2024,11/27/2024,F,Vote on a proposal to approve the 2024 Equity Incentive Plan.,MG,-1,-1,Shareholder Rights,Audit Related,Compensation,Omnibus Stock Plan,Compensation,Omnibus Stock Plan
"2025-01-14||75903M||Election of Director to serve until the Company's 2025 Annual Meeting of Shareholders and until their successors are elected and qualified, or until their earlier death, resignation or removal: David A. Tenwick||-1||-1",P22079,"REGIONAL HEALTH PROPERTIES, INC.",BN,75903M,1/14/2025,12/23/2024,12/2/2024,F,"Election of Director to serve until the Company's 2025 Annual Meeting of Shareholders and until their successors are elected and qualified, or until their earlier death, resignation or removal: David A. Tenwick",MG,-1,-1,Board of Directors,Elections,Board of Directors,Elections,Board of Directors,Elections
"2025-01-14||75903M||Election of Director to serve until the Company's 2025 Annual Meeting of Shareholders and until their successors are elected and qualified, or until their earlier death, resignation or removal: Kenneth W. Taylor||-1||-1",P22079,"REGIONAL HEALTH PROPERTIES, INC.",BN,75903M,1/14/2025,12/23/2024,12/2/2024,F,"Election of Director to serve until the Company's 2025 Annual Meeting of Shareholders and until their successors are elected and qualified, or until their earlier death, resignation or removal: Kenneth W. Taylor",MG,-1,-1,Board of Directors,Elections,Board of Directors,Elections,Board of Directors,Elections
2025-04-16||7591EP||Election of Director: Joia M. Johnson||-1||-1,P24485,REGIONS FINANCIAL CORPORATION,SH,7591EP,4/16/2025,3/13/2025,2/18/2025,F,Election of Director: Joia M. Johnson,MG,-1,-1,Board of Directors,Elections,Board of Directors,Elections,Board of Directors,Elections
2025-04-16||7591EP||Election of Director: Alison S. Rand||-1||-1,P22499,REGIONS FINANCIAL CORPORATION,BN,7591EP,4/16/2025,3/13/2025,2/18/2025,F,Election of Director: Alison S. Rand,MG,-1,-1,Board of Directors,Elections,Board of Directors,Elections,Board of Directors,Elections
2025-04-16||7591EP||Election of Director: James T. Prokopanko||-1||-1,P22499,REGIONS FINANCIAL CORPORATION,BN,7591EP,4/16/2025,3/13/2025,2/18/2025,F,Election of Director: James T. Prokopanko,MG,-1,-1,Board of Directors,Elections,Board of Directors,Elections,Board of Directors,Elections
2025-04-16||7591EP||Advisory Vote to Approve Regions' Executive Compensation.||-1||-1,P22499,REGIONS FINANCIAL CORPORATION,BN,7591EP,4/16/2025,3/13/2025,2/18/2025,F,Advisory Vote to Approve Regions' Executive Compensation.,MG,-1,-1,Compensation,Articles/ByLaws,Compensation,Executive Pay Evaluation (Say on Pay),Compensation,Executive Pay Evaluation (Say on Pay)
"2025-04-16||7591EP||Election of Director: John M. Turner, Jr.||-1||-1",P22499,REGIONS FINANCIAL CORPORATION,BN,7591EP,4/16/2025,3/13/2025,2/18/2025,F,"Election of Director: John M. Turner, Jr.",MG,-1,-1,Board of Directors,Elections,Board of Directors,Elections,Board of Directors,Elections
2025-04-16||7591EP||Election of Director: J. Thomas Hill||-1||-1,P22499,REGIONS FINANCIAL CORPORATION,BN,7591EP,4/16/2025,3/13/2025,2/18/2025,F,Election of Director: J. Thomas Hill,MG,-1,-1,Board of Directors,Elections,Board of Directors,Elections,Board of Directors,Elections
2025-04-01||76090R||Approve the share issuance proposal for the equity line of credit under the Nasdaq rules.||-1||-1,Z89694,"RESHAPE LIFESCIENCES, INC",BN,76090R,4/1/2025,3/21/2025,3/3/2025,F,Approve the share issuance proposal for the equity line of credit under the Nasdaq rules.,MG,-1,-1,Corporate Actions,Spin Off,Shareholder Equity,Stock Issuance,Shareholder Equity,Stock Issuance
2025-02-27||749527||Approval of an amendment to our Amended and Restated Certificate of Incorporation to add a federal forum selection provision.||-1||-1,P22301,"REV GROUP, INC.",BN,749527,2/27/2025,1/22/2025,1/3/2025,F,Approval of an amendment to our Amended and Restated Certificate of Incorporation to add a federal forum selection provision.,MG,-1,-1,Corporate Governance,Investment Advisory Agreement,Corporate Structure,Miscellaneous Corporate Actions,Corporate Structure,Miscellaneous Corporate Actions
"2025-01-17||76135L||Approval of the adjournment of the Special Meeting of the Stockholders (the ""Special Meeting"") to the extent there are insufficient proxies at the Special Meeting to approve the Reverse Stock Split.||-1||-1",S03195,"REVELATION BIOSCIENCES, INC.",BN,76135L,1/17/2025,12/19/2024,12/3/2024,F,"Approval of the adjournment of the Special Meeting of the Stockholders (the ""Special Meeting"") to the extent there are insufficient proxies at the Special Meeting to approve the Reverse Stock Split.",MG,-1,-1,Shareholder Rights,Omnibus Stock Plan,Shareholder Rights,Meeting Management,Shareholder Rights,Meeting Management
2025-01-17||76135L||Approve the change of domicile of the Company from the State of Delaware to the State of Nevada.||-1||-1,S03195,"REVELATION BIOSCIENCES, INC.",BN,76135L,1/17/2025,12/19/2024,12/3/2024,F,Approve the change of domicile of the Company from the State of Delaware to the State of Nevada.,MG,-1,-1,Corporate Structure,Supermajority Voting,Corporate Structure,Miscellaneous Corporate Actions,Corporate Structure,Miscellaneous Corporate Actions
"2025-05-02||786598||Election of Director for the ensuing year and until their successors are elected and qualified: Clarke R. Brown, Jr.||-1||-1",P25381,"SAGA COMMUNICATIONS, INC.",BN,786598,5/2/2025,4/14/2025,3/14/2025,F,"Election of Director for the ensuing year and until their successors are elected and qualified: Clarke R. Brown, Jr.",MG,-1,-1,Board of Directors,Elections,Board of Directors,Elections,Board of Directors,Elections
2025-05-02||786598||Election of Director for the ensuing year and until their successors are elected and qualified: Roy F. Coppedge III||-1||-1,P25381,"SAGA COMMUNICATIONS, INC.",BN,786598,5/2/2025,4/14/2025,3/14/2025,F,Election of Director for the ensuing year and until their successors are elected and qualified: Roy F. Coppedge III,MG,-1,-1,Board of Directors,Elections,Board of Directors,Elections,Board of Directors,Elections
"2025-05-02||786598||To approve, by a non-binding advisory vote, a resolution approving the compensation of our named executive officers as described in the proxy statement.||-1||-1",P25381,"SAGA COMMUNICATIONS, INC.",BN,786598,5/2/2025,4/14/2025,3/14/2025,F,"To approve, by a non-binding advisory vote, a resolution approving the compensation of our named executive officers as described in the proxy statement.",MG,-1,-1,Compensation,Articles/ByLaws,Compensation,Executive Pay Evaluation (Say on Pay),Compensation,Executive Pay Evaluation (Say on Pay)
2025-05-02||786598||Election of Director for the ensuing year and until their successors are elected and qualified: Warren S. Lada||-1||-1,P25381,"SAGA COMMUNICATIONS, INC.",BN,786598,5/2/2025,4/14/2025,3/14/2025,F,Election of Director for the ensuing year and until their successors are elected and qualified: Warren S. Lada,MG,-1,-1,Board of Directors,Elections,Board of Directors,Elections,Board of Directors,Elections
2025-03-10||801056||Election of Director: David V. Hedley III||-1||-1,P24568,SANMINA CORPORATION,BN,801056,3/10/2025,1/28/2025,1/17/2025,F,Election of Director: David V. Hedley III,MG,-1,-1,Board of Directors,Elections,Board of Directors,Elections,Board of Directors,Elections
"2025-03-10||801056||To approve the reservation of an additional 1,000,000 shares of common stock for issuance under the 2019 Equity Incentive Plan of Sanmina Corporation.||-1||-1",P24568,SANMINA CORPORATION,BN,801056,3/10/2025,1/28/2025,1/17/2025,F,"To approve the reservation of an additional 1,000,000 shares of common stock for issuance under the 2019 Equity Incentive Plan of Sanmina Corporation.",MG,-1,-1,Compensation,Health,Compensation,Omnibus Stock Plan,Shareholder Equity,Stock Issuance
"2025-03-10||801056||To consider and vote upon the stockholder proposal entitled ""Proposal 5 - Special Shareholder Meeting Improvement,"" requesting that the Board of Directors take action as necessary to amend the existing right for shareholders to call a special meeting.||-1||-1",P24568,SANMINA CORPORATION,BN,801056,3/10/2025,1/28/2025,1/17/2025,N,"To consider and vote upon the stockholder proposal entitled ""Proposal 5 - Special Shareholder Meeting Improvement,"" requesting that the Board of Directors take action as necessary to amend the existing right for shareholders to call a special meeting.",SH,-1,-1,,,Shareholder Rights,Meeting Management,Shareholder Rights,Meeting Management
"2025-03-10||801056||To approve, on an advisory (non-binding) basis, the compensation of Sanmina Corporation's named executive officers.||-1||-1",P24568,SANMINA CORPORATION,BN,801056,3/10/2025,1/28/2025,1/17/2025,F,"To approve, on an advisory (non-binding) basis, the compensation of Sanmina Corporation's named executive officers.",MG,-1,-1,Compensation,Articles/ByLaws,Compensation,Executive Pay Evaluation (Say on Pay),Compensation,Executive Pay Evaluation (Say on Pay)
"2025-01-16||42237K||To approve, for purposes of complying with the NYSE American LLC listing rules, of the issuance of 20% or more of the Company's issued and outstanding Common Stock as of December 5, 2024 pursuant to a securities purchase agreement with the purchasers named therein (the ""Investors""), dated December 5, 2024, including upon the conversion of the senior secured convertible notes issued pursuant to the Purchase Agreement and the exercise of warrants issued or issuable pursuant to the Purchase Agreement (the ""Share Issuance Proposal"").||-1||-1",S02513,"SCORPIUS HOLDINGS, INC.",BN,42237K,1/16/2025,12/24/2024,12/13/2024,F,"To approve, for purposes of complying with the NYSE American LLC listing rules, of the issuance of 20% or more of the Company's issued and outstanding Common Stock as of December 5, 2024 pursuant to a securities purchase agreement with the purchasers named therein (the ""Investors""), dated December 5, 2024, including upon the conversion of the senior secured convertible notes issued pursuant to the Purchase Agreement and the exercise of warrants issued or issuable pursuant to the Purchase Agreement (the ""Share Issuance Proposal"").",MG,-1,-1,,,Corporate Structure,Miscellaneous Corporate Actions,Shareholder Equity,Authorize Stock Increase
"2025-01-16||42237K||The Company seeks approval to amend its Third Amended and Restated Certificate of Incorporation, as outlined in Appendix A of the proxy statement. The amendment would authorize the Board of Directors to execute a reverse stock split of Common Stock (par value $0.0002 per share), including treasury shares, at a ratio between 1-for-5 and 1-for-35. The exact ratio will be determined and announced by the Board, which also reserves the right to abandon the proposal if necessary. This is termed the ""Reverse Stock Split Proposal.""||-1||-1",S02513,"SCORPIUS HOLDINGS, INC.",BN,42237K,1/16/2025,12/24/2024,12/13/2024,F,"The Company seeks approval to amend its Third Amended and Restated Certificate of Incorporation, as outlined in Appendix A of the proxy statement. The amendment would authorize the Board of Directors to execute a reverse stock split of Common Stock (par value $0.0002 per share), including treasury shares, at a ratio between 1-for-5 and 1-for-35. The exact ratio will be determined and announced by the Board, which also reserves the right to abandon the proposal if necessary. This is termed the ""Reverse Stock Split Proposal.""",MG,-1,-1,Corporate Actions,Miscellaneous Shareholder Rights,Corporate Structure,Miscellaneous Corporate Actions,Shareholder Equity,Stock Splits/Reverse Stock Splits
"2025-01-16||42237K||To approve an adjournment of the Special Meeting of Stockholders to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event there are not sufficient votes in favor of the Reverse Stock Split Proposal or the Share Issuance Proposal.||-1||-1",S02513,"SCORPIUS HOLDINGS, INC.",BN,42237K,1/16/2025,12/24/2024,12/13/2024,F,"To approve an adjournment of the Special Meeting of Stockholders to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event there are not sufficient votes in favor of the Reverse Stock Split Proposal or the Share Issuance Proposal.",MG,-1,-1,Shareholder Rights,Omnibus Stock Plan,Shareholder Rights,Meeting Management,Shareholder Rights,Meeting Management
"2025-04-10||81750R||Approval, on an advisory (non-binding) basis, of the compensation of our named executive officers.||-1||-1",P23105,"SERES THERAPEUTICS, INC.",BN,81750R,4/10/2025,3/21/2025,2/13/2025,F,"Approval, on an advisory (non-binding) basis, of the compensation of our named executive officers.",MG,-1,-1,Compensation,Articles/ByLaws,Compensation,Executive Pay Evaluation (Say on Pay),Compensation,Executive Pay Evaluation (Say on Pay)
"2025-05-01||82489W||Approval, by an advisory vote, of the compensation of the Company's Named Executive Officers (i.e., ""say-on-pay"" proposal).||-1||-1",P23069,"SHOALS TECHNOLOGIES GROUP, INC.",BN,82489W,5/1/2025,3/27/2025,3/10/2025,F,"Approval, by an advisory vote, of the compensation of the Company's Named Executive Officers (i.e., ""say-on-pay"" proposal).",MG,-1,-1,Compensation,Articles/ByLaws,Compensation,Executive Pay Evaluation (Say on Pay),Compensation,Executive Pay Evaluation (Say on Pay)
"2024-12-19||829392||Approve adoption, on an advisory basis, of a non-binding resolution approving the compensation of the Company's named executive officers, as described in the Proxy Statement under ""Executive Compensation.""||-1||-1",P20420,SINTX TECHNOLOGIES INC,BN,829392,12/19/2024,11/21/2024,11/6/2024,F,"Approve adoption, on an advisory basis, of a non-binding resolution approving the compensation of the Company's named executive officers, as described in the Proxy Statement under ""Executive Compensation.""",MG,-1,-1,Compensation,Articles/ByLaws,Compensation,Executive Pay Evaluation (Say on Pay),Compensation,Executive Pay Evaluation (Say on Pay)
"2024-12-19||829392||To approve an amendment to our 2020 Equity Incentive Plan to increase the authorized number of shares of common stock of the Company issuable under all awards granted under the plan by 333,650 shares.||-1||-1",P20420,SINTX TECHNOLOGIES INC,BN,829392,12/19/2024,11/21/2024,11/6/2024,F,"To approve an amendment to our 2020 Equity Incentive Plan to increase the authorized number of shares of common stock of the Company issuable under all awards granted under the plan by 333,650 shares.",MG,-1,-1,Shareholder Equity,Acquisition Agreement,Compensation,Omnibus Stock Plan,Shareholder Equity,Authorize Stock Increase
2025-03-11||83570H||Advisory approval of the named executive officer compensation (the say-on-pay vote).||-1||-1,P22542,"SONOS, INC.",BN,83570H,3/11/2025,1/31/2025,1/13/2025,F,Advisory approval of the named executive officer compensation (the say-on-pay vote).,MG,-1,-1,Compensation,Articles/ByLaws,Compensation,Executive Pay Evaluation (Say on Pay),Compensation,Executive Pay Evaluation (Say on Pay)
"2025-04-10||871607||To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the attached Proxy Statement.||-1||-1",P22733,"SYNOPSYS, INC.",BN,871607,4/10/2025,2/27/2025,2/10/2025,F,"To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the attached Proxy Statement.",MG,-1,-1,Compensation,Articles/ByLaws,Compensation,Executive Pay Evaluation (Say on Pay),Compensation,Executive Pay Evaluation (Say on Pay)
2025-04-10||871607||Election of Director to hold office until the next annual meeting of stockholders or until their successors have been elected: Jeannine P. Sargent||-1||-1,P22733,"SYNOPSYS, INC.",BN,871607,4/10/2025,2/27/2025,2/10/2025,F,Election of Director to hold office until the next annual meeting of stockholders or until their successors have been elected: Jeannine P. Sargent,MG,-1,-1,Board of Directors,Elections,Board of Directors,Elections,Board of Directors,Elections
2025-04-10||871607||Election of Director to hold office until the next annual meeting of stockholders or until their successors have been elected: Janice D. Chaffin||-1||-1,P22733,"SYNOPSYS, INC.",BN,871607,4/10/2025,2/27/2025,2/10/2025,F,Election of Director to hold office until the next annual meeting of stockholders or until their successors have been elected: Janice D. Chaffin,MG,-1,-1,Board of Directors,Elections,Board of Directors,Elections,Board of Directors,Elections
2025-04-10||871607||Election of Director to hold office until the next annual meeting of stockholders or until their successors have been elected: Bruce R. Chizen||-1||-1,P22733,"SYNOPSYS, INC.",BN,871607,4/10/2025,2/27/2025,2/10/2025,F,Election of Director to hold office until the next annual meeting of stockholders or until their successors have been elected: Bruce R. Chizen,MG,-1,-1,Board of Directors,Elections,Board of Directors,Elections,Board of Directors,Elections
"2024-12-03||87978U||To approve a series of alternate amendments to the Company's Restated Certificate of Incorporation to effect, at the option of the Company's Board of Directors, a reverse stock split of the Company's common stock at a ratio in the range of 1-for-2 to 1-for-15, inclusive, as determined by the Company's Board of Directors in its sole discretion.||-1||-1",Z88881,"TEMPEST THERAPEUTICS, INC.",BN,87978U,12/3/2024,11/14/2024,11/5/2024,F,"To approve a series of alternate amendments to the Company's Restated Certificate of Incorporation to effect, at the option of the Company's Board of Directors, a reverse stock split of the Company's common stock at a ratio in the range of 1-for-2 to 1-for-15, inclusive, as determined by the Company's Board of Directors in its sole discretion.",MG,-1,-1,Corporate Structure,Supermajority Voting,Shareholder Equity,Stock Splits/Reverse Stock Splits,Shareholder Equity,Stock Splits/Reverse Stock Splits
"2025-04-15||88224Q||To approve, on an advisory basis, the 2024 compensation of the Company's named executive officers as described in the Proxy Statement;||-1||-1",P24569,"TEXAS CAPITAL BANCSHARES, INC.",BN,88224Q,4/15/2025,3/10/2025,2/19/2025,F,"To approve, on an advisory basis, the 2024 compensation of the Company's named executive officers as described in the Proxy Statement;",MG,-1,-1,Compensation,Articles/ByLaws,Compensation,Executive Pay Evaluation (Say on Pay),Compensation,Executive Pay Evaluation (Say on Pay)
"2025-01-27||810186||Approval, on an advisory basis, of the compensation of the Company's named executive officers.||-1||-1",P20355,THE SCOTTS MIRACLE-GRO COMPANY,BN,810186,1/27/2025,12/24/2024,12/2/2024,F,"Approval, on an advisory basis, of the compensation of the Company's named executive officers.",MG,-1,-1,Compensation,Articles/ByLaws,Compensation,Executive Pay Evaluation (Say on Pay),Compensation,Executive Pay Evaluation (Say on Pay)
"2025-05-02||89357L||To approve an amendment to our amended and restated certificate of Inc, as amended, in the form attached to the proxy statement as Annex A, to, at the discretion of our Board, effect a reverse stock split of our outstanding shares of common stock, par value $0.0001 per share, at any time prior to the one-year anniversary date of the Special Meeting, at a ratio, ranging from one-for- ten (1:10) to one-for-forty (1:40), with the exact ratio to be set within that range at the discretion of our Board without further approval (the ""Reverse Stock Split Proposal"").||-1||-1",Z90062,"TRANSCODE THERAPEUTICS, INC.",BN,89357L,5/2/2025,4/16/2025,4/3/2025,F,"To approve an amendment to our amended and restated certificate of Inc, as amended, in the form attached to the proxy statement as Annex A, to, at the discretion of our Board, effect a reverse stock split of our outstanding shares of common stock, par value $0.0001 per share, at any time prior to the one-year anniversary date of the Special Meeting, at a ratio, ranging from one-for- ten (1:10) to one-for-forty (1:40), with the exact ratio to be set within that range at the discretion of our Board without further approval (the ""Reverse Stock Split Proposal"").",MG,-1,-1,Corporate Structure,Supermajority Voting,Corporate Structure,Miscellaneous Corporate Actions,Shareholder Equity,Stock Splits/Reverse Stock Splits
"2025-02-25||89357L||To approve, (i) for purposes of complying with Nasdaq Listing Rule 5635(d), the full issuance of shares of common stock, par value $0.0001 per share by TransCode Therapeutics, Inc. upon exercise of the Series C and the Series D (together with the Series C Warrants, the ""Warrants""), (ii) a series of adjustments to the exercise price of the Warrants and an increase in the underlying Common Stock of the Warrants, (iii) an alternative cashless exercise feature in the Series D Warrants (iv) an adjustment to the exercise price and number of Warrants.||-1||-1",Z89155,"TRANSCODE THERAPEUTICS, INC.",BN,89357L,2/25/2025,1/9/2025,12/23/2024,F,"To approve, (i) for purposes of complying with Nasdaq Listing Rule 5635(d), the full issuance of shares of common stock, par value $0.0001 per share by TransCode Therapeutics, Inc. upon exercise of the Series C and the Series D (together with the Series C Warrants, the ""Warrants""), (ii) a series of adjustments to the exercise price of the Warrants and an increase in the underlying Common Stock of the Warrants, (iii) an alternative cashless exercise feature in the Series D Warrants (iv) an adjustment to the exercise price and number of Warrants.",MG,-1,-1,,,Shareholder Equity,Warrants/Bonds/Notes,Shareholder Equity,Warrants/Bonds/Notes
"2025-04-30||89677Y||Election of Class II Director to serve until the 2028 Annual Meeting of the Company's stockholders, or until their respective successors are duly elected and qualified: Gilbert E. Ahye||-1||-1",P25283,TRIPLEPOINT VENTURE GROWTH BDC CORP.,BN,89677Y,4/30/2025,3/17/2025,3/7/2025,F,"Election of Class II Director to serve until the 2028 Annual Meeting of the Company's stockholders, or until their respective successors are duly elected and qualified: Gilbert E. Ahye",MG,-1,-1,Board of Directors,Elections,Board of Directors,Elections,Board of Directors,Elections
"2025-04-30||89677Y||Election of Class II Director to serve until the 2028 Annual Meeting of the Company's stockholders, or until their respective successors are duly elected and qualified: Steven P. Bird||-1||-1",P25283,TRIPLEPOINT VENTURE GROWTH BDC CORP.,BN,89677Y,4/30/2025,3/17/2025,3/7/2025,F,"Election of Class II Director to serve until the 2028 Annual Meeting of the Company's stockholders, or until their respective successors are duly elected and qualified: Steven P. Bird",MG,-1,-1,Board of Directors,Elections,Board of Directors,Elections,Board of Directors,Elections
"2025-04-30||89677Y||Election of Class II Director to serve until the 2028 Annual Meeting of the Company's stockholders, or until their respective successors are duly elected and qualified: Kimberley H. Vogel||-1||-1",P25283,TRIPLEPOINT VENTURE GROWTH BDC CORP.,BN,89677Y,4/30/2025,3/17/2025,3/7/2025,F,"Election of Class II Director to serve until the 2028 Annual Meeting of the Company's stockholders, or until their respective successors are duly elected and qualified: Kimberley H. Vogel",MG,-1,-1,Board of Directors,Elections,Board of Directors,Board Classification,Board of Directors,Elections
2025-04-29||89832Q||Advisory vote to approve Truist's executive compensation program.||-1||-1,P24498,TRUIST FINANCIAL CORPORATION,BN,89832Q,4/29/2025,3/24/2025,2/20/2025,F,Advisory vote to approve Truist's executive compensation program.,MG,-1,-1,Compensation,Animal Rights,Compensation,Executive Pay Evaluation (Say on Pay),Compensation,Executive Pay Evaluation (Say on Pay)
2025-01-14||904708||Election of Class III Director to serve for a term of three years until the 2028 Annual Meeting of Shareholders and until their respective successors are duly elected and qualified: Sergio A. Pupkin||-1||-1,P20987,UNIFIRST CORPORATION,BN,904708,1/14/2025,12/9/2024,11/15/2024,F,Election of Class III Director to serve for a term of three years until the 2028 Annual Meeting of Shareholders and until their respective successors are duly elected and qualified: Sergio A. Pupkin,MG,-1,-1,Board of Directors,Elections,Board of Directors,Elections,Board of Directors,Elections
2025-05-02||917488||Election of Director to serve a three year term and until their successor is elected and qualified: Carrie Leigh||-1||-1,P27196,"UTAH MEDICAL PRODUCTS, INC.",BN,917488,5/2/2025,4/9/2025,3/3/2025,F,Election of Director to serve a three year term and until their successor is elected and qualified: Carrie Leigh,MG,-1,-1,Board of Directors,Elections,Board of Directors,Elections,Board of Directors,Elections
"2025-01-15||928251||To approve an amendment to the Company's Amended and Restated Certificate of Incorporation, in substantially the form attached to the proxy statement as Annex A, to, at the discretion of the BOD of the Company, effect a reverse stock split with respect to the Company's issued and outstanding common stock, par value $0.00001 per share, including stock held by the Company as treasury shares, at a ratio of 1-for-2 to 1-for-240, with the ratio within such Range to be determined at the discretion of the Board and included in a public announcement.||-1||-1",Z88995,"VIRPAX PHARMACEUTICALS, INC.",BN,928251,1/15/2025,12/13/2024,11/21/2024,F,"To approve an amendment to the Company's Amended and Restated Certificate of Incorporation, in substantially the form attached to the proxy statement as Annex A, to, at the discretion of the BOD of the Company, effect a reverse stock split with respect to the Company's issued and outstanding common stock, par value $0.00001 per share, including stock held by the Company as treasury shares, at a ratio of 1-for-2 to 1-for-240, with the ratio within such Range to be determined at the discretion of the Board and included in a public announcement.",MG,-1,-1,Corporate Actions,Supermajority Voting,Corporate Structure,Miscellaneous Corporate Actions,Shareholder Equity,Stock Splits/Reverse Stock Splits
"2025-01-15||928251||To approve an adjournment of the 2025 Special Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event there are not sufficient votes in favor of the Reverse Stock Split Proposal and/or the Director Proposal (the ""Adjournment Proposal"" or ""Proposal 3"").||-1||-1",Z88995,"VIRPAX PHARMACEUTICALS, INC.",BN,928251,1/15/2025,12/13/2024,11/21/2024,F,"To approve an adjournment of the 2025 Special Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event there are not sufficient votes in favor of the Reverse Stock Split Proposal and/or the Director Proposal (the ""Adjournment Proposal"" or ""Proposal 3"").",MG,-1,-1,Shareholder Rights,Omnibus Stock Plan,Shareholder Rights,Meeting Management,Shareholder Rights,Meeting Management
"2025-04-30||961765||To approve the Eleventh Amended and Restated Westwood Holdings Group, Inc. Stock Incentive Plan.||-1||-1",P24596,"WESTWOOD HOLDINGS GROUP, INC.",BN,961765,4/30/2025,4/2/2025,3/3/2025,F,"To approve the Eleventh Amended and Restated Westwood Holdings Group, Inc. Stock Incentive Plan.",MG,-1,-1,Compensation,Health,Compensation,Stock Option Plans,Compensation,Omnibus Stock Plan
"2025-02-03||97382D||To approve an amendment to our Amended and Restated Windtree Therapeutics, Inc. 2020 Equity Incentive Plan to increase the number of shares of common stock, par value $0.001 per share, authorized for issuance under such plan from 41,010 shares to 1,141,010 shares.||-1||-1",S05496,"WINDTREE THERAPEUTICS, INC.",BN,97382D,2/3/2025,1/10/2025,12/20/2024,F,"To approve an amendment to our Amended and Restated Windtree Therapeutics, Inc. 2020 Equity Incentive Plan to increase the number of shares of common stock, par value $0.001 per share, authorized for issuance under such plan from 41,010 shares to 1,141,010 shares.",MG,-1,-1,Compensation,Health,Compensation,Omnibus Stock Plan,Compensation,Omnibus Stock Plan
"2025-02-03||97382D||To approve an amendment to our Amended and Restated Certificate of Incorporation, as amended, to effect a reverse stock split of our outstanding shares of common stock, par value $0.001 per share by a ratio of any whole number between 1-for-5 and 1-for 50, the implementation and timing of which shall be subject to the discretion of the Board of Directors.||-1||-1",S05496,"WINDTREE THERAPEUTICS, INC.",BN,97382D,2/3/2025,1/10/2025,12/20/2024,F,"To approve an amendment to our Amended and Restated Certificate of Incorporation, as amended, to effect a reverse stock split of our outstanding shares of common stock, par value $0.001 per share by a ratio of any whole number between 1-for-5 and 1-for 50, the implementation and timing of which shall be subject to the discretion of the Board of Directors.",MG,-1,-1,Shareholder Equity,Financial Statements,Corporate Structure,Miscellaneous Corporate Actions,Shareholder Equity,Stock Splits/Reverse Stock Splits
"2025-04-10||98420U||To approve an amendment to the Company's Amended and Restated Certificate of Incorporation to classify the Board of Directors into two classes, with the directors in each class to serve staggered two-year terms.||-1||-1",S09917,"XWELL, INC.",BN,98420U,4/10/2025,3/4/2025,2/14/2025,F,"To approve an amendment to the Company's Amended and Restated Certificate of Incorporation to classify the Board of Directors into two classes, with the directors in each class to serve staggered two-year terms.",MG,-1,-1,Board of Directors,Executive Pay Evaluation (Say on Pay),Board of Directors,Board Classification,Board of Directors,Board Classification
"2025-04-10||98420U||To approve an amendment to the XWELL, Inc. 2020 Equity Incentive Plan (as amended, the ""2020 Plan"") to (i) increase the aggregate number of shares of Common Stock reserved for issuance under the 2020 Plan by 2,500,000 shares to a total of 3,125,000 shares and (ii) increase the maximum number of shares of Common Stock subject to awards granted during a single fiscal year to any director who is not an employee or consultant during the fiscal year to $750,000.||-1||-1",S09917,"XWELL, INC.",BN,98420U,4/10/2025,3/4/2025,2/14/2025,F,"To approve an amendment to the XWELL, Inc. 2020 Equity Incentive Plan (as amended, the ""2020 Plan"") to (i) increase the aggregate number of shares of Common Stock reserved for issuance under the 2020 Plan by 2,500,000 shares to a total of 3,125,000 shares and (ii) increase the maximum number of shares of Common Stock subject to awards granted during a single fiscal year to any director who is not an employee or consultant during the fiscal year to $750,000.",MG,-1,-1,,,Compensation,Stock Option Plans,Shareholder Equity,Authorize Stock Increase
"2025-01-10||98980G||To approve an amendment and restatement of the Zscaler, Inc. FY2018 Equity Incentive Plan.||-1||-1",P19619,"ZSCALER, INC.",BN,98980G,1/10/2025,12/3/2024,11/13/2024,F,"To approve an amendment and restatement of the Zscaler, Inc. FY2018 Equity Incentive Plan.",MG,-1,-1,Compensation,Health,Compensation,Stock Option Plans,Compensation,Omnibus Stock Plan
"2025-03-04||98987D||The approval of the issuance of up to an aggregate of 1,637,000 shares of the Company's common stock issuable upon the exercise of certain warrants to purchase the Company's common stock, in accordance with Nasdaq Listing Rule 5635(d).||-1||-1",S03116,"ZYVERSA THERAPEUTICS, INC.",BN,98987D,3/4/2025,1/23/2025,1/7/2025,F,"The approval of the issuance of up to an aggregate of 1,637,000 shares of the Company's common stock issuable upon the exercise of certain warrants to purchase the Company's common stock, in accordance with Nasdaq Listing Rule 5635(d).",MG,-1,-1,Shareholder Equity,,Shareholder Equity,Warrants/Bonds/Notes,Shareholder Equity,Warrants/Bonds/Notes
